Australian Statistics on Medicines 2011
Table 2
COMMUNITY PRESCRIPTION DRUG USE,
IN DDD/1000/DAY, FOR 2009 TO 2011
Table 2 lists most drugs on the Australian market by defined daily dose (DDD) per 1000 of the population per day from 2009 to 2011. To be listed in Table 2 the drugs need to have an assigned DDD. Items are arranged on the ATC code by generic name and the DDD/1000/day is given for both the subsidised ‘PBS/RPBS’ and the non-subsidised ‘survey’ components.
DDDs/1000 population/day for combination products are reported in terms of the DDD for each constituent where appropriate, ie, the ASM accounts for drugs in combination products as if they were administered as plain products. In editions prior to 2008, DDDs for combination products were not accounted for. For instance in atorvastatin and amlodipine combination product, the DDD component will be reported in 2 separate locations: the contribution to C10AA05—Atorvastatin and C08CA01—Amlodipine. DDDs entry for these drugs as a combination product is flagged as “combination” where the DDDs are part of a single product then the entry will be flagged as “plain”.
Note that not all combination products are included in table 2. Combination drugs will only be reported in terms of DDD of each constituent where:
- the constituent drugs were also available as plain drugs on the PBS;
- the combination was one of the usual forms of these drugs prescribed;
- the constituent drugs had independent actions ; and
- the WHO Defined Daily Dose was consistent across the various forms of the constituent drugs.
In addition, Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2012 is used in all statistics published in this edition (refer to WHO collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs 2012).
An index by the second level of the ATC classification follows:
- ALIMENTARY TRACT AND METABOLISM
- A01 - STOMATOLOGICAL PREPARATIONS
- A02 - DRUGS FOR ACID RELATED DISORDERS
- A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
- A04 - ANTIEMETICS AND ANTINAUSEANTS
- A05 - BILE AND LIVER THERAPY
- A06 - LAXATIVES
- A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
- A08 - ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
- A10 - ANTIDIABETIC THERAPY
- A11 - VITAMINS
- A12 - MINERAL SUPPLEMENTS
- A14 - ANABOLIC AGENTS FOR SYSTEMIC USE
- BLOOD AND BLOOD FORMING ORGANS
- CARDIOVASCULAR SYSTEM
- C01 - CARDIAC THERAPY
- C02 - ANTIHYPERTENSIVES
- C03 - DIURETICS
- C04 - PERIPHERAL VASODILATORS
- C07 - BETA BLOCKING AGENTS
- C08 - CALCIUM CHANNEL BLOCKERS
- C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
- C10 - LIPID MODIFYING AGENTS PLAIN
- DERMATOLOGICALS
- GENITO URINARY SYSTEM AND SEX HORMONES
- G01 - GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
- G02 - OTHER GYNAECOLOGICALS
- G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
- G04 - UROLOGICALS
- SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES
- H01 - PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES
- H02 - CORTICOSTEROIDS FOR SYSTEMIC USE
- H03 - THYROID THERAPY
- H04 - PANCREATIC HORMONES
- H05 - CALCIUM HOMEOSTASIS
- GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
- J01 - ANTIBACTERIALS FOR SYSTEMIC USE
- J02 - ANTIMYCOTICS FOR SYSTEMIC USE
- J04 - ANTIMYCOBACTERIALS
- J05 - ANTIVIRALS FOR SYSTEMIC USE
- ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- MUSCULO-SKELETAL SYSTEM
- M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
- M03 - MUSCLE RELAXANTS
- M04 - ANTIGOUT PREPARATIONS
- M05 - DRUGS FOR TREATMENT OF BONE DISEASES
- M09 - OTHER DRUGS FOR DISORD. OF MUSCULO-SKELETAL SYST.
- NERVOUS SYSTEM
- N02 - ANALGESICS
- N03 - ANTIEPILEPTICS
- N04 - ANTI-PARKINSON DRUGS
- N05 - PSYCHOLEPTICS
- N06 - PSYCHOANALEPTICS
- N07 - OTHER NERVOUS SYSTEM DRUGS
- ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
- RESPIRATORY SYSTEM
- R01 - NASAL PREPARATIONS
- R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
- R05 - COUGH AND COLD PREPARATIONS
- R06 - ANTIHISTAMINES FOR SYSTEMIC USE
- SENSORY ORGANS
- VARIOUS
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
AMPHOTERICIN |
|||||
A01AB04 |
PBS/RPBS |
Plain |
0.076 |
0.072 |
0.074 |
SURVEY |
Plain |
0.027 |
0.025 |
0.026 |
|
CHLORHEXIDINE |
|||||
A01AB03 |
PBS/RPBS |
Plain |
0.003 |
0.003 |
0.003 |
SURVEY |
Plain |
0.002 |
0.002 |
0.003 |
|
MICONAZOLE |
|||||
A01AB09 |
SURVEY |
Plain |
0.002 |
0.002 |
0.002 |
NYSTATIN |
|||||
A01AB11 |
PBS/RPBS |
Plain |
0.024 |
0.024 |
0.025 |
SURVEY |
Plain |
0.006 |
0.005 |
0.006 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
CIMETIDINE |
|||||
A02BA01 |
PBS/RPBS |
Plain |
0.075 |
0.044 |
0.011 |
SURVEY |
Plain |
0.030 |
0.026 |
0.011 |
|
FAMOTIDINE |
|||||
A02BA03 |
PBS/RPBS |
Plain |
0.368 |
0.326 |
0.290 |
SURVEY |
Plain |
0.075 |
0.059 |
0.057 |
|
NIZATIDINE |
|||||
A02BA04 |
PBS/RPBS |
Plain |
0.401 |
0.434 |
0.472 |
SURVEY |
Plain |
0.105 |
0.108 |
0.118 |
|
RANITIDINE HYDROCHLORIDE |
|||||
A02BA02 |
PBS/RPBS |
Plain |
3.090 |
2.902 |
2.725 |
SURVEY |
Plain |
0.577 |
0.558 |
0.549 |
|
PROSTAGLANDINS |
|||||
MISOPROSTOL |
|||||
A02BB01 |
PBS/RPBS |
Plain |
0.007 |
0.006 |
0.006 |
PBS/RPBS |
Combination |
0.001 |
0.001 |
0.001 |
|
PBS/RPBS |
Total |
0.008 |
0.007 |
0.007 |
|
SURVEY |
Plain |
0.001 |
0.002 |
0.002 |
|
SURVEY |
Combination |
0.001 |
0.002 |
0.001 |
|
SURVEY |
Total |
0.002 |
0.004 |
0.003 |
|
PROTON PUMP INHIBITORS |
|||||
ESOMEPRAZOLE |
|||||
A02BC05 |
PBS/RPBS |
Plain |
21.650 |
22.390 |
21.455 |
SURVEY |
Plain |
0.073 |
0.097 |
2.700 |
|
LANSOPRAZOLE |
|||||
A02BC03 |
PBS/RPBS |
Plain |
2.947 |
1.972 |
1.751 |
SURVEY |
Plain |
0.027 |
0.328 |
0.529 |
|
OMEPRAZOLE |
|||||
A02BC01 |
PBS/RPBS |
Plain |
12.420 |
11.615 |
10.872 |
SURVEY |
Plain |
2.623 |
2.309 |
2.195 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
2.623 |
2.309 |
2.195 |
|
PANTOPRAZOLE |
|||||
A02BC02 |
PBS/RPBS |
Plain |
14.691 |
13.996 |
14.068 |
SURVEY |
Plain |
0.206 |
2.358 |
3.168 |
|
RABEPRAZOLE |
|||||
A02BC04 |
PBS/RPBS |
Plain |
9.327 |
9.950 |
10.396 |
SURVEY |
Plain |
0.029 |
0.038 |
0.048 |
|
OTHER DRUGS FOR PEPTIC ULCER AND GORD |
|||||
SUCRALFATE |
|||||
A02BX02 |
PBS/RPBS |
Plain |
0.044 |
0.047 |
0.050 |
DRUGS FOR PEPTIC ULCER AND GORD |
|||||
SURVEY |
Plain |
0.011 |
0.011 |
0.011 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
MEBEVERINE HYDROCHLORIDE |
|||||
A03AA04 |
PBS/RPBS |
Plain |
0.041 |
0.037 |
0.034 |
SURVEY |
Plain |
0.304 |
0.310 |
0.313 |
|
SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUND |
|||||
GLYCOPYRROLATE |
|||||
A03AB02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PROPANTHELINE |
|||||
A03AB05 |
PBS/RPBS |
Plain |
0.097 |
0.088 |
0.077 |
SURVEY |
Plain |
0.020 |
0.018 |
0.016 |
|
PAPAVERINE AND DERIVATIVES |
|||||
PAPAVERINE |
|||||
A03AD01 |
SURVEY |
Plain |
0.021 |
0.000 |
0.000 |
BELLADONNA AND DERIVATIVES PLAIN |
|||||
BELLADONNA ALKALOIDS TERTIARY AMINES |
|||||
ATROPINE |
|||||
A03BA01 |
PBS/RPBS |
Plain |
0.006 |
0.006 |
0.004 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
HYOSCYAMINE SULPHATE with ATROPINE SULPHATE with HYOSCINE HYDROBROMIDE |
|||||
A03BA04 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUND |
|||||
BUTYLSCOPOLAMINE |
|||||
A03BB01 |
PBS/RPBS |
Plain |
0.002 |
0.002 |
0.003 |
SURVEY |
Plain |
0.034 |
0.031 |
0.028 |
|
PROPULSIVES |
|||||
PROPULSIVES |
|||||
DOMPERIDONE |
|||||
A03FA03 |
PBS/RPBS |
Plain |
0.612 |
0.660 |
0.708 |
SURVEY |
Plain |
0.228 |
0.253 |
0.275 |
|
METOCLOPRAMIDE HYDROCHLORIDE |
|||||
A03FA01 |
PBS/RPBS |
Plain |
0.679 |
0.690 |
0.706 |
SURVEY |
Plain |
0.407 |
0.384 |
0.400 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
0.407 |
0.384 |
0.400 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
DOLASETRON MESYLATE |
|||||
A04AA04 |
PBS/RPBS |
Plain |
0.005 |
0.004 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
GRANISETRON |
|||||
A04AA02 |
PBS/RPBS |
Plain |
0.026 |
0.028 |
0.020 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ONDANSETRON |
|||||
A04AA01 |
PBS/RPBS |
Plain |
0.039 |
0.043 |
0.045 |
SURVEY |
Plain |
0.011 |
0.013 |
0.018 |
|
PALONOSETRON |
|||||
A04AA05 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.005 |
TROPISETRON |
|||||
A04AA03 |
PBS/RPBS |
Plain |
0.011 |
0.010 |
0.009 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
VARIOUS ANTIEMETICS |
|||||
APREPITANT |
|||||
A04AD12 |
PBS/RPBS |
Plain |
0.013 |
0.015 |
0.018 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
SCOPOLAMINE |
|||||
A04AD01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
URSODEOXYCHOLIC ACID |
|||||
A05AA02 |
PBS/RPBS |
Plain |
0.189 |
0.200 |
0.210 |
SURVEY |
Plain |
0.005 |
0.006 |
0.009 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
DOCUSATE SODIUM |
|||||
A06AA02 |
PBS/RPBS |
Plain |
0.018 |
0.018 |
0.017 |
SURVEY |
Plain |
0.081 |
0.109 |
0.129 |
|
LIQUID PARAFFIN |
|||||
A06AA01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
CONTACT LAXATIVES |
|||||
BISACODYL |
|||||
A06AB02 |
PBS/RPBS |
Plain |
0.476 |
0.446 |
0.436 |
SURVEY |
Plain |
0.028 |
0.024 |
0.027 |
|
BULK PRODUCERS |
|||||
PSYLLIUM HYDROPHILIC MUCILLOID |
|||||
A06AC01 |
PBS/RPBS |
Plain |
0.237 |
0.205 |
0.181 |
SURVEY |
Plain |
0.026 |
0.031 |
0.034 |
|
OSMOTICALLY ACTING LAXATIVES |
|||||
LACTULOSE |
|||||
A06AD11 |
PBS/RPBS |
Plain |
2.059 |
2.041 |
2.038 |
SURVEY |
Plain |
0.239 |
0.263 |
0.270 |
|
LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE |
|||||
A06AD11 |
SURVEY |
Plain |
0.000 |
0.001 |
0.001 |
MACROGOL |
|||||
A06AD15 |
PBS/RPBS |
Plain |
2.722 |
3.669 |
4.518 |
SURVEY |
Plain |
0.191 |
0.197 |
0.259 |
|
SODIUM PHOSPHATE |
|||||
A06AD17 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ENEMAS |
|||||
BISACODYL |
|||||
A06AG02 |
PBS/RPBS |
Plain |
0.002 |
0.002 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
PERIPHERAL OPIOID RECEPTOR ANTAGONISTS |
|||||
METHYLNALTREXONE BROMIDE |
|||||
A06AH01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER LAXATIVES |
|||||
GLYCEROL |
|||||
A06AX01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
NEOMYCIN SULPHATE |
|||||
A07AA01 |
PBS/RPBS |
Plain |
0.001 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
NYSTATIN |
|||||
A07AA02 |
PBS/RPBS |
Plain |
0.075 |
0.073 |
0.070 |
SURVEY |
Plain |
0.069 |
0.068 |
0.061 |
|
VANCOMYCIN |
|||||
A07AA09 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ANTIPROPULSIVES |
|||||
ANTIPROPULSIVES |
|||||
DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE |
|||||
A07DA01 |
PBS/RPBS |
Plain |
0.128 |
0.122 |
0.116 |
SURVEY |
Plain |
0.060 |
0.052 |
0.050 |
|
LOPERAMIDE HYDROCHLORIDE |
|||||
A07DA03 |
PBS/RPBS |
Plain |
0.296 |
0.304 |
0.309 |
SURVEY |
Plain |
0.060 |
0.053 |
0.054 |
|
INTESTINAL ANTIINFLAMMATORY AGENTS |
|||||
AMINOSALICYLIC ACID AND SIMILAR AGENTS |
|||||
BALSALAZIDE |
|||||
A07EC04 |
PBS/RPBS |
Plain |
0.061 |
0.065 |
0.064 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
MESALAZINE |
|||||
A07EC02 |
PBS/RPBS |
Plain |
1.081 |
1.195 |
1.347 |
SURVEY |
Plain |
0.006 |
0.008 |
0.012 |
|
OLSALAZINE SODIUM |
|||||
A07EC03 |
PBS/RPBS |
Plain |
0.140 |
0.130 |
0.118 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
|
SULPHASALAZINE |
|||||
A07EC01 |
PBS/RPBS |
Plain |
1.399 |
1.389 |
1.375 |
SURVEY |
Plain |
0.018 |
0.017 |
0.015 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
PHENTERMINE |
|||||
A08AA01 |
SURVEY |
Plain |
1.772 |
1.689 |
2.002 |
SIBUTRAMINE |
|||||
A08AA10 |
SURVEY |
Plain |
0.796 |
0.401 |
0.000 |
PERIPHERALLY ACTING ANTIOBESITY PRODUCTS |
|||||
ORLISTAT |
|||||
A08AB01 |
PBS/RPBS |
Plain |
0.002 |
0.001 |
0.001 |
SURVEY |
Plain |
0.016 |
0.008 |
0.009 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
INSULIN (BEEF) |
|||||
A10AB02 |
PBS/RPBS |
Plain |
0.007 |
0.006 |
0.005 |
INSULIN (HUMAN) |
|||||
A10AB01 |
PBS/RPBS |
Plain |
0.687 |
0.605 |
0.538 |
SURVEY |
Plain |
0.006 |
0.005 |
0.009 |
|
INSULIN ASPART |
|||||
A10AB05 |
PBS/RPBS |
Plain |
3.393 |
3.734 |
4.079 |
SURVEY |
Plain |
0.030 |
0.029 |
0.021 |
|
INSULIN GLULISINE |
|||||
A10AB06 |
PBS/RPBS |
Plain |
0.229 |
0.274 |
0.298 |
SURVEY |
Plain |
0.001 |
0.002 |
0.004 |
|
INSULIN LISPRO |
|||||
A10AB04 |
PBS/RPBS |
Plain |
0.869 |
0.873 |
0.899 |
SURVEY |
Plain |
0.008 |
0.014 |
0.009 |
|
INSULINS AND ANALOGUES INTERMEDIATE-ACTING |
|||||
INSULIN (BEEF) |
|||||
A10AC02 |
PBS/RPBS |
Plain |
0.010 |
0.008 |
0.007 |
SURVEY |
Plain |
0.004 |
0.002 |
0.002 |
|
INSULIN (HUMAN) |
|||||
A10AC01 |
PBS/RPBS |
Plain |
1.405 |
1.192 |
1.029 |
SURVEY |
Plain |
0.028 |
0.025 |
0.031 |
|
INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST-ACTING |
|||||
INSULIN (HUMAN) |
|||||
A10AD01 |
PBS/RPBS |
Plain |
2.293 |
2.069 |
1.821 |
SURVEY |
Plain |
0.042 |
0.026 |
0.038 |
|
INSULIN ASPART/PROTAMINE ASPART |
|||||
A10AD30 |
PBS/RPBS |
Plain |
2.869 |
3.217 |
3.516 |
SURVEY |
Plain |
0.026 |
0.015 |
0.009 |
|
INSULIN LISPRO |
|||||
A10AD04 |
PBS/RPBS |
Plain |
0.416 |
0.492 |
0.539 |
SURVEY |
Plain |
0.001 |
0.001 |
0.003 |
|
INSULINS AND ANALOGUES LONG-ACTING |
|||||
INSULIN DETEMIR |
|||||
A10AE05 |
PBS/RPBS |
Plain |
0.699 |
0.763 |
0.813 |
SURVEY |
Plain |
0.009 |
0.007 |
0.003 |
|
INSULIN GLARGINE |
|||||
A10AE04 |
PBS/RPBS |
Plain |
4.430 |
5.103 |
5.777 |
SURVEY |
Plain |
0.043 |
0.046 |
0.049 |
|
ORAL BLOOD GLUCOSE LOWERING DRUGS |
|||||
BIGUANIDES |
|||||
METFORMIN HYDROCHLORIDE |
|||||
ORAL BLOOD GLUCOSE LOWERING DRUGS |
|||||
A10BA02 |
PBS/RPBS |
Plain |
12.724 |
13.338 |
13.636 |
PBS/RPBS |
Combination |
0.531 |
0.795 |
1.325 |
|
PBS/RPBS |
Total |
13.255 |
14.133 |
14.961 |
|
SURVEY |
Plain |
4.341 |
4.306 |
4.357 |
|
SURVEY |
Combination |
0.099 |
0.098 |
0.101 |
|
SURVEY |
Total |
4.440 |
4.404 |
4.458 |
|
SULFONAMIDES UREA DERIVATIVES |
|||||
GLIBENCLAMIDE |
|||||
A10BB01 |
PBS/RPBS |
Plain |
0.631 |
0.536 |
0.445 |
PBS/RPBS |
Combination |
0.437 |
0.434 |
0.412 |
|
PBS/RPBS |
Total |
1.068 |
0.970 |
0.857 |
|
SURVEY |
Plain |
0.122 |
0.101 |
0.078 |
|
SURVEY |
Combination |
0.158 |
0.157 |
0.157 |
|
SURVEY |
Total |
0.280 |
0.258 |
0.235 |
|
GLICLAZIDE |
|||||
A10BB09 |
PBS/RPBS |
Plain |
13.516 |
12.832 |
12.763 |
SURVEY |
Plain |
3.012 |
2.717 |
2.722 |
|
GLIMEPIRIDE |
|||||
A10BB12 |
PBS/RPBS |
Plain |
2.051 |
1.896 |
1.684 |
SURVEY |
Plain |
0.568 |
0.486 |
0.418 |
|
GLIPIZIDE |
|||||
A10BB07 |
PBS/RPBS |
Plain |
0.414 |
0.364 |
0.308 |
SURVEY |
Plain |
0.070 |
0.067 |
0.064 |
|
ALPHA GLUCOSIDASE INHIBITORS |
|||||
ACARBOSE |
|||||
A10BF01 |
PBS/RPBS |
Plain |
0.147 |
0.140 |
0.137 |
SURVEY |
Plain |
0.006 |
0.003 |
0.004 |
|
THIAZOLIDINEDIONES |
|||||
PIOGLITAZONE HYDROCHLORIDE |
|||||
A10BG03 |
PBS/RPBS |
Plain |
1.686 |
1.807 |
1.654 |
SURVEY |
Plain |
0.008 |
0.008 |
0.006 |
|
ROSIGLITAZONE |
|||||
A10BG02 |
PBS/RPBS |
Plain |
0.473 |
0.282 |
0.139 |
PBS/RPBS |
Combination |
0.273 |
0.219 |
0.138 |
|
PBS/RPBS |
Total |
0.746 |
0.501 |
0.277 |
|
SURVEY |
Plain |
0.003 |
0.002 |
0.002 |
|
SURVEY |
Combination |
0.001 |
0.001 |
0.002 |
|
SURVEY |
Total |
0.004 |
0.003 |
0.004 |
|
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS |
|||||
SAXAGLIPTIN |
|||||
A10BH03 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.045 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
ORAL BLOOD GLUCOSE LOWERING DRUGS |
|||||
SITAGLIPTIN |
|||||
A10BH01 |
PBS/RPBS |
Plain |
0.678 |
0.898 |
1.051 |
PBS/RPBS |
Combination |
0.044 |
0.402 |
0.940 |
|
PBS/RPBS |
Total |
0.722 |
1.300 |
1.991 |
|
SURVEY |
Plain |
0.016 |
0.014 |
0.015 |
|
SURVEY |
Combination |
0.000 |
0.002 |
0.007 |
|
SURVEY |
Total |
0.016 |
0.016 |
0.022 |
|
VILDAGLIPTIN |
|||||
A10BH02 |
PBS/RPBS |
Plain |
0.000 |
0.048 |
0.218 |
PBS/RPBS |
Combination |
0.000 |
0.000 |
0.149 |
|
PBS/RPBS |
Total |
0.000 |
0.048 |
0.367 |
|
SURVEY |
Plain |
0.000 |
0.001 |
0.002 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
0.000 |
0.001 |
0.002 |
|
OTHER BLOOD GLUCOSE LOWERING DRUGS |
|||||
EXENATIDE |
|||||
A10BX04 |
PBS/RPBS |
Plain |
0.000 |
0.037 |
0.231 |
SURVEY |
Plain |
0.007 |
0.007 |
0.007 |
|
REPAGLINIDE |
|||||
A10BX02 |
SURVEY |
Plain |
0.001 |
0.001 |
0.004 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
VITAMIN A |
|||||
A11CA01 |
SURVEY |
Plain |
0.005 |
0.003 |
0.006 |
VITAMIN D AND ANALOGUES |
|||||
CALCITRIOL |
|||||
A11CC04 |
PBS/RPBS |
Plain |
0.493 |
0.479 |
0.456 |
SURVEY |
Plain |
0.010 |
0.010 |
0.010 |
|
VITAMIN B1,PLAIN AND IN COMB. WITH VITAMIN B6 AND B12 |
|||||
THIAMINE (VITAMIN B1) PLAIN |
|||||
THIAMINE HYDROCHLORIDE |
|||||
A11DA01 |
PBS/RPBS |
Plain |
0.427 |
0.444 |
0.486 |
SURVEY |
Plain |
0.892 |
1.007 |
1.010 |
|
OTHER PLAIN VITAMIN PREPARATIONS |
|||||
OTHER PLAIN VITAMIN PREPARATIONS |
|||||
PYRIDOXINE HYDROCHLORIDE |
|||||
A11HA02 |
SURVEY |
Plain |
0.009 |
0.007 |
0.009 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
CALCIUM (DIFFERENT SALTS IN COMBINATION) |
|||||
A12AA20 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
CALCIUM CARBONATE |
|||||
A12AA04 |
PBS/RPBS |
Plain |
0.094 |
0.113 |
0.124 |
PBS/RPBS |
Combination |
1.532 |
1.515 |
1.851 |
|
PBS/RPBS |
Total |
1.626 |
1.628 |
1.975 |
|
SURVEY |
Plain |
0.198 |
0.189 |
0.151 |
|
SURVEY |
Combination |
0.044 |
0.030 |
0.033 |
|
SURVEY |
Total |
0.242 |
0.219 |
0.184 |
|
CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS |
|||||
CALCIUM CARBONATE with CHOLECALCIFEROL |
|||||
A12AX |
SURVEY |
Plain |
0.018 |
0.017 |
0.020 |
POTASSIUM |
|||||
POTASSIUM |
|||||
POTASSIUM CHLORIDE |
|||||
A12BA01 |
PBS/RPBS |
Plain |
1.447 |
1.387 |
1.366 |
SURVEY |
Plain |
0.155 |
0.145 |
0.143 |
|
OTHER MINERAL SUPPLEMENTS |
|||||
ZINC |
|||||
ZINC SULPHATE |
|||||
A12CB01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
SELENIUM |
|||||
SELENIUM |
|||||
A12CE01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ALIMENTARY TRACT AND METABOLISM |
|||||
NANDROLONE DECANOATE |
|||||
A14AB01 |
PBS/RPBS |
Plain |
0.027 |
0.023 |
0.007 |
SURVEY |
Plain |
0.018 |
0.013 |
0.008 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
BLOOD AND BLOOD FORMING ORGANS |
|||||
PHENINDIONE |
|||||
B01AA02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
WARFARIN |
|||||
B01AA03 |
PBS/RPBS |
Plain |
5.125 |
5.330 |
5.239 |
SURVEY |
Plain |
1.165 |
1.180 |
1.156 |
|
HEPARIN GROUP |
|||||
DALTEPARIN |
|||||
B01AB04 |
PBS/RPBS |
Plain |
0.051 |
0.047 |
0.048 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ENOXAPARIN |
|||||
B01AB05 |
PBS/RPBS |
Plain |
1.683 |
1.935 |
2.199 |
SURVEY |
Plain |
0.016 |
0.023 |
0.029 |
|
HEPARIN CALCIUM |
|||||
B01AB01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
HEPARIN SODIUM |
|||||
B01AB01 |
PBS/RPBS |
Plain |
0.034 |
0.041 |
0.045 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
HEPARINISED SALINE |
|||||
B01AB01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN |
|||||
ABCIXIMAB |
|||||
B01AC13 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ASPIRIN |
|||||
B01AC06 |
PBS/RPBS |
Plain |
17.147 |
16.121 |
15.097 |
PBS/RPBS |
Combination |
0.968 |
1.885 |
2.797 |
|
PBS/RPBS |
Total |
18.115 |
18.006 |
17.894 |
|
SURVEY |
Plain |
1.387 |
1.239 |
1.277 |
|
SURVEY |
Combination |
0.002 |
0.003 |
0.007 |
|
SURVEY |
Total |
1.389 |
1.242 |
1.284 |
|
CLOPIDOGREL |
|||||
B01AC04 |
PBS/RPBS |
Plain |
10.499 |
10.116 |
9.305 |
PBS/RPBS |
Combination |
0.008 |
0.937 |
1.875 |
|
PBS/RPBS |
Total |
10.507 |
11.053 |
11.180 |
|
SURVEY |
Plain |
0.053 |
0.039 |
0.058 |
|
SURVEY |
Combination |
0.000 |
0.002 |
0.005 |
|
SURVEY |
Total |
0.053 |
0.041 |
0.063 |
|
DIPYRIDAMOLE |
|||||
B01AC07 |
PBS/RPBS |
Plain |
0.179 |
0.157 |
0.140 |
PBS/RPBS |
Combination |
1.920 |
1.895 |
1.844 |
|
PBS/RPBS |
Total |
2.099 |
2.052 |
1.984 |
|
SURVEY |
Plain |
0.004 |
0.003 |
0.001 |
|
ANTITHROMBOTIC AGENTS |
|||||
SURVEY |
Combination |
0.004 |
0.003 |
0.003 |
|
SURVEY |
Total |
0.008 |
0.006 |
0.004 |
|
EPTIFIBATIDE |
|||||
B01AC16 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ILOPROST |
|||||
B01AC11 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.000 |
PRASUGREL |
|||||
B01AC22 |
PBS/RPBS |
Plain |
0.000 |
0.035 |
0.105 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
TICLOPIDINE HYDROCHLORIDE |
|||||
B01AC05 |
PBS/RPBS |
Plain |
0.006 |
0.004 |
0.002 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
TIROFIBAN |
|||||
B01AC17 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ENZYMES |
|||||
DROTRECOGIN ALFA |
|||||
B01AD10 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
RETEPLASE |
|||||
B01AD07 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
TENECTEPLASE |
|||||
B01AD11 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
DIRECT THROMBIN INHIBITORS |
|||||
BIVALIRUDIN |
|||||
B01AE06 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
DABIGATRAN |
|||||
B01AE07 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.009 |
|
OTHER ANTITHROMBOTIC AGENTS |
|||||
FONDAPARINUX SODIUM |
|||||
B01AX05 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
RIVAROXABAN |
|||||
B01AX06 |
PBS/RPBS |
Plain |
0.009 |
0.081 |
0.133 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
BLOOD AND BLOOD FORMING ORGANS |
|||||
TRANEXAMIC ACID |
|||||
B02AA02 |
PBS/RPBS |
Plain |
0.121 |
0.127 |
0.139 |
SURVEY |
Plain |
0.003 |
0.003 |
0.003 |
|
VITAMIN K AND OTHER HAEMOSTATICS |
|||||
VITAMIN K |
|||||
PHYTOMENADIONE |
|||||
B02BA01 |
SURVEY |
Plain |
0.004 |
0.001 |
0.000 |
OTHER SYSTEMIC HEMOSTATICS |
|||||
ELTROMBOPAG |
|||||
B02BX05 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ROMIPLOSTIM |
|||||
B02BX04 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.002 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
BLOOD AND BLOOD FORMING ORGANS |
|||||
FERROUS FUMARATE |
|||||
B03AA02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.006 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
FERROUS SULPHATE |
|||||
B03AA07 |
PBS/RPBS |
Plain |
0.036 |
0.037 |
0.038 |
SURVEY |
Plain |
0.432 |
0.393 |
0.352 |
|
IRON TRIVALENT, PARENTERAL PREPARATIONS |
|||||
IRON POLYMALTOSE COMPLEX |
|||||
B03AC03 |
PBS/RPBS |
Plain |
0.035 |
0.037 |
0.039 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
SACCHARATED IRON OXIDE |
|||||
B03AC02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
VITAMIN B12 AND FOLIC ACID |
|||||
VITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES) |
|||||
CYANOCOBALAMIN |
|||||
B03BA01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
HYDROXOCOBALAMIN |
|||||
B03BA03 |
PBS/RPBS |
Plain |
5.446 |
5.555 |
5.578 |
SURVEY |
Plain |
0.744 |
0.747 |
0.765 |
|
FOLIC ACID AND DERIVATIVES |
|||||
FOLIC ACID |
|||||
B03BB01 |
PBS/RPBS |
Plain |
1.479 |
1.343 |
1.201 |
SURVEY |
Plain |
0.157 |
0.134 |
0.115 |
|
OTHER ANTIANAEMIC PREPARATIONS |
|||||
OTHER ANTIANAEMIC PREPARATIONS |
|||||
DARBEPOETIN ALPHA |
|||||
B03XA02 |
PBS/RPBS |
Plain |
0.187 |
0.186 |
0.186 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
|
EPOETIN ALPHA |
|||||
B03XA01 |
PBS/RPBS |
Plain |
0.031 |
0.028 |
0.027 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
EPOETIN BETA |
|||||
B03XA01 |
PBS/RPBS |
Plain |
0.030 |
0.033 |
0.024 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
EPOETIN LAMDA |
|||||
B03XA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ERYTHROPOIETIN |
|||||
B03XA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA |
|||||
B03XA03 |
PBS/RPBS |
Plain |
0.000 |
0.004 |
0.013 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
DIGOXIN |
|||||
C01AA05 |
PBS/RPBS |
Plain |
3.236 |
3.055 |
2.893 |
SURVEY |
Plain |
0.409 |
0.387 |
0.367 |
|
ANTIARRHYTHMICS CLASS I AND III |
|||||
ANTIARRHYTHMICS CLASS IA |
|||||
DISOPYRAMIDE |
|||||
C01BA03 |
PBS/RPBS |
Plain |
0.030 |
0.027 |
0.025 |
SURVEY |
Plain |
0.003 |
0.002 |
0.002 |
|
ANTIARRHYTHMICS CLASS IB |
|||||
LIGNOCAINE HYDROCHLORIDE |
|||||
C01BB01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
MEXILETINE HYDROCHLORIDE |
|||||
C01BB02 |
PBS/RPBS |
Plain |
0.015 |
0.011 |
0.000 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
|
ANTIARRHYTHMICS CLASS IC |
|||||
FLECAINIDE ACETATE |
|||||
C01BC04 |
PBS/RPBS |
Plain |
0.572 |
0.619 |
0.666 |
SURVEY |
Plain |
0.002 |
0.003 |
0.005 |
|
ANTIARRHYTHMICS CLASS III |
|||||
AMIODARONE HYDROCHLORIDE |
|||||
C01BD01 |
PBS/RPBS |
Plain |
1.123 |
1.086 |
1.059 |
SURVEY |
Plain |
0.124 |
0.119 |
0.145 |
|
DRONEDARONE |
|||||
C01BD07 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
|||||
ADRENERGIC AGENTS |
|||||
ADRENALINE |
|||||
C01CA24 |
PBS/RPBS |
Plain |
0.040 |
0.042 |
0.036 |
SURVEY |
Plain |
0.003 |
0.003 |
0.001 |
|
EPHEDRINE |
|||||
C01CA26 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
VASODILATORS USED IN CARDIAC DISEASES |
|||||
ORGANIC NITRATES |
|||||
GLYCERYL TRINITRATE |
|||||
C01DA02 |
PBS/RPBS |
Plain |
4.114 |
3.843 |
3.626 |
SURVEY |
Plain |
0.198 |
0.182 |
0.206 |
|
ISOSORBIDE DINITRATE |
|||||
C01DA08 |
PBS/RPBS |
Plain |
0.101 |
0.091 |
0.062 |
SURVEY |
Plain |
0.005 |
0.005 |
0.006 |
|
ISOSORBIDE MONONITRATE |
|||||
VASODILATORS USED IN CARDIAC DISEASES |
|||||
C01DA14 |
PBS/RPBS |
Plain |
6.976 |
6.635 |
6.297 |
SURVEY |
Plain |
0.408 |
0.341 |
0.323 |
|
OTHER VASODILATORS USED IN CARDIAC DISEASES |
|||||
NICORANDIL |
|||||
C01DX16 |
PBS/RPBS |
Plain |
0.010 |
0.010 |
0.010 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER CARDIAC PREPARATIONS |
|||||
OTHER CARDIAC PREPARATIONS |
|||||
ADENOSINE |
|||||
C01EB10 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
IVABRADINE |
|||||
C01EB17 |
SURVEY |
Plain |
0.008 |
0.052 |
0.107 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
METHYLDOPA |
|||||
C02AB01 |
PBS/RPBS |
Plain |
0.451 |
0.441 |
0.428 |
SURVEY |
Plain |
0.097 |
0.092 |
0.098 |
|
IMIDAZOLINE RECEPTOR AGONISTS |
|||||
CLONIDINE |
|||||
C02AC01 |
PBS/RPBS |
Plain |
0.363 |
0.371 |
0.379 |
SURVEY |
Plain |
0.063 |
0.064 |
0.063 |
|
MOXONIDINE |
|||||
C02AC05 |
PBS/RPBS |
Plain |
0.517 |
0.990 |
1.413 |
SURVEY |
Plain |
0.139 |
0.273 |
0.361 |
|
ANTIADRENERGIC AGENTS PERIPHERALLY ACTING |
|||||
ALPHA - ADRENOCEPTOR BLOCKING AGENTS |
|||||
PRAZOSIN HYDROCHLORIDE |
|||||
C02CA01 |
PBS/RPBS |
Plain |
2.968 |
2.851 |
2.755 |
SURVEY |
Plain |
0.507 |
0.470 |
0.451 |
|
ARTERIOLAR SMOOTH MUSCLE AGENTS ACTING ON |
|||||
HYDRAZINOPHTHALAZINE DERIVATIVES |
|||||
HYDRALAZINE HYDROCHLORIDE |
|||||
C02DB02 |
PBS/RPBS |
Plain |
0.435 |
0.465 |
0.488 |
SURVEY |
Plain |
0.087 |
0.083 |
0.077 |
|
PYRIMIDINE DERIVATIVES |
|||||
MINOXIDIL |
|||||
C02DC01 |
PBS/RPBS |
Plain |
0.030 |
0.030 |
0.026 |
SURVEY |
Plain |
0.007 |
0.007 |
0.007 |
|
OTHER ANTIHYPERTENSIVES |
|||||
OTHER ANTHIYPERTENSIVES |
|||||
AMBRISENTAN |
|||||
C02KX02 |
PBS/RPBS |
Plain |
0.000 |
0.002 |
0.002 |
BOSENTAN |
|||||
C02KX01 |
PBS/RPBS |
Plain |
0.031 |
0.029 |
0.009 |
SURVEY |
Plain |
0.000 |
0.001 |
0.001 |
|
SITAXENTAN |
|||||
C02KX03 |
PBS/RPBS |
Plain |
0.005 |
0.005 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
HYDROCHLOROTHIAZIDE |
|||||
C03AA03 |
PBS/RPBS |
Plain |
0.904 |
0.908 |
0.884 |
PBS/RPBS |
Combination |
10.019 |
10.527 |
10.950 |
|
PBS/RPBS |
Total |
10.923 |
11.435 |
11.834 |
|
SURVEY |
Plain |
0.276 |
0.241 |
0.245 |
|
SURVEY |
Combination |
3.578 |
3.308 |
3.008 |
|
SURVEY |
Total |
3.854 |
3.549 |
3.253 |
|
LOW-CEILING DIURETICS EXCL. THIAZIDES |
|||||
SULFONAMIDES PLAIN |
|||||
CHLORTHALIDONE |
|||||
C03BA04 |
PBS/RPBS |
Plain |
0.309 |
0.289 |
0.268 |
SURVEY |
Plain |
0.096 |
0.083 |
0.081 |
|
INDAPAMIDE |
|||||
C03BA11 |
PBS/RPBS |
Plain |
3.792 |
3.438 |
3.070 |
PBS/RPBS |
Combination |
2.521 |
2.447 |
2.265 |
|
PBS/RPBS |
Total |
6.313 |
5.885 |
5.335 |
|
SURVEY |
Plain |
1.035 |
0.924 |
0.792 |
|
SURVEY |
Combination |
1.063 |
0.965 |
0.838 |
|
SURVEY |
Total |
2.098 |
1.889 |
1.630 |
|
HIGH-CEILING DIURETICS |
|||||
SULFONAMIDES PLAIN |
|||||
BUMETANIDE |
|||||
C03CA02 |
SURVEY |
Plain |
0.071 |
0.076 |
0.094 |
FRUSEMIDE |
|||||
C03CA01 |
PBS/RPBS |
Plain |
17.302 |
17.214 |
17.079 |
SURVEY |
Plain |
1.299 |
1.226 |
1.200 |
|
ARYLOXYACETIC ACID DERIVATIVES |
|||||
ETHACRYNIC ACID |
|||||
C03CC01 |
PBS/RPBS |
Plain |
0.026 |
0.028 |
0.029 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
POTASSIUM-SPARING AGENTS |
|||||
ALDOSTERONE ANTAGONISTS |
|||||
EPLERENONE |
|||||
C03DA04 |
PBS/RPBS |
Plain |
0.021 |
0.026 |
0.034 |
SURVEY |
Plain |
0.001 |
0.002 |
0.002 |
|
SPIRONOLACTONE |
|||||
C03DA01 |
PBS/RPBS |
Plain |
1.706 |
1.757 |
1.806 |
SURVEY |
Plain |
0.653 |
0.573 |
0.635 |
|
OTHER POTASSIUM-SPARING AGENTS |
|||||
AMILORIDE HYDROCHLORIDE |
|||||
C03DB01 |
PBS/RPBS |
Plain |
0.113 |
0.106 |
0.060 |
POTASSIUM-SPARING AGENTS |
|||||
SURVEY |
Plain |
0.037 |
0.037 |
0.023 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
PHENTOLAMINE MESYLATE |
|||||
C04AB01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PURINE DERIVATIVES |
|||||
OXPENTIFYLLINE |
|||||
C04AD03 |
SURVEY |
Plain |
0.004 |
0.002 |
0.007 |
OTHER PERIPHERAL VASODILATORS |
|||||
CILOSTAZOL |
|||||
C04AX33 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PHENOXYBENZAMINE HYDROCHLORIDE |
|||||
C04AX02 |
PBS/RPBS |
Plain |
0.009 |
0.008 |
0.009 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
OXPRENOLOL HYDROCHLORIDE |
|||||
C07AA02 |
PBS/RPBS |
Plain |
0.021 |
0.019 |
0.019 |
SURVEY |
Plain |
0.013 |
0.015 |
0.011 |
|
PINDOLOL |
|||||
C07AA03 |
PBS/RPBS |
Plain |
0.193 |
0.171 |
0.137 |
SURVEY |
Plain |
0.035 |
0.029 |
0.036 |
|
PROPRANOLOL HYDROCHLORIDE |
|||||
C07AA05 |
PBS/RPBS |
Plain |
0.853 |
0.844 |
0.830 |
SURVEY |
Plain |
0.421 |
0.414 |
0.391 |
|
SOTALOL HYDROCHLORIDE |
|||||
C07AA07 |
PBS/RPBS |
Plain |
1.761 |
1.756 |
1.753 |
SURVEY |
Plain |
0.449 |
0.429 |
0.418 |
|
BETA BLOCKING AGENTS PLAIN SELECTIVE |
|||||
ATENOLOL |
|||||
C07AB03 |
PBS/RPBS |
Plain |
8.944 |
8.647 |
8.315 |
SURVEY |
Plain |
2.643 |
2.412 |
2.278 |
|
BISOPROLOL |
|||||
C07AB07 |
PBS/RPBS |
Plain |
0.864 |
1.082 |
1.296 |
SURVEY |
Plain |
0.009 |
0.007 |
0.006 |
|
METOPROLOL SUCCINATE |
|||||
C07AB02 |
PBS/RPBS |
Plain |
0.262 |
0.283 |
0.299 |
SURVEY |
Plain |
0.001 |
0.000 |
0.002 |
|
METOPROLOL TARTRATE |
|||||
C07AB02 |
PBS/RPBS |
Plain |
6.195 |
6.342 |
6.455 |
SURVEY |
Plain |
1.401 |
1.348 |
1.339 |
|
NEBIVOLOL |
|||||
C07AB12 |
PBS/RPBS |
Plain |
0.000 |
0.022 |
0.105 |
SURVEY |
Plain |
0.000 |
0.000 |
0.003 |
|
ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS |
|||||
CARVEDILOL |
|||||
C07AG02 |
PBS/RPBS |
Plain |
2.005 |
1.939 |
1.840 |
SURVEY |
Plain |
0.010 |
0.008 |
0.010 |
|
LABETALOL HYDROCHLORIDE |
|||||
C07AG01 |
PBS/RPBS |
Plain |
0.089 |
0.088 |
0.085 |
SURVEY |
Plain |
0.050 |
0.048 |
0.049 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
AMLODIPINE |
|||||
C08CA01 |
PBS/RPBS |
Plain |
12.672 |
12.603 |
12.181 |
PBS/RPBS |
Combination |
4.375 |
6.368 |
9.923 |
|
PBS/RPBS |
Total |
17.047 |
18.971 |
22.104 |
|
SURVEY |
Plain |
4.113 |
3.852 |
3.552 |
|
SURVEY |
Combination |
0.008 |
0.040 |
0.442 |
|
SURVEY |
Total |
4.121 |
3.892 |
3.994 |
|
FELODIPINE |
|||||
C08CA02 |
PBS/RPBS |
Plain |
5.903 |
5.468 |
4.974 |
PBS/RPBS |
Combination |
0.194 |
0.226 |
0.228 |
|
PBS/RPBS |
Total |
6.097 |
5.694 |
5.202 |
|
SURVEY |
Plain |
1.286 |
1.128 |
0.993 |
|
SURVEY |
Combination |
0.104 |
0.104 |
0.099 |
|
SURVEY |
Total |
1.390 |
1.232 |
1.092 |
|
LERCANIPIDINE |
|||||
C08CA13 |
PBS/RPBS |
Plain |
9.035 |
9.155 |
9.160 |
PBS/RPBS |
Combination |
0.245 |
0.355 |
0.344 |
|
PBS/RPBS |
Total |
9.280 |
9.510 |
9.504 |
|
SURVEY |
Plain |
2.452 |
2.410 |
2.255 |
|
SURVEY |
Combination |
0.037 |
0.090 |
0.162 |
|
SURVEY |
Total |
2.489 |
2.500 |
2.417 |
|
NIFEDIPINE |
|||||
C08CA05 |
PBS/RPBS |
Plain |
3.740 |
3.480 |
3.191 |
SURVEY |
Plain |
0.966 |
0.866 |
0.785 |
|
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS |
|||||
PHENYLALKYLAMINE DERIVATIVES |
|||||
VERAPAMIL HYDROCHLORIDE |
|||||
C08DA01 |
PBS/RPBS |
Plain |
3.290 |
3.124 |
2.933 |
PBS/RPBS |
Combination |
0.197 |
0.147 |
0.148 |
|
PBS/RPBS |
Total |
3.487 |
3.271 |
3.081 |
|
SURVEY |
Plain |
0.788 |
0.725 |
0.664 |
|
SURVEY |
Combination |
0.006 |
0.098 |
0.095 |
|
SURVEY |
Total |
0.794 |
0.823 |
0.759 |
|
BENZOTHIAZEPINE DERIVATIVES |
|||||
DILTIAZEM HYDROCHLORIDE |
|||||
C08DB01 |
PBS/RPBS |
Plain |
4.313 |
4.163 |
3.963 |
SURVEY |
Plain |
0.832 |
0.793 |
0.769 |
|
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
|||||
OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
|||||
PERHEXILINE MALEATE |
|||||
C08EX02 |
PBS/RPBS |
Plain |
0.198 |
0.189 |
0.184 |
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
|||||
SURVEY |
Plain |
0.002 |
0.001 |
0.001 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
CAPTOPRIL |
|||||
C09AA01 |
PBS/RPBS |
Plain |
0.585 |
0.459 |
0.373 |
SURVEY |
Plain |
0.023 |
0.031 |
0.020 |
|
ENALAPRIL MALEATE |
|||||
C09AA02 |
PBS/RPBS |
Plain |
3.378 |
2.960 |
2.452 |
PBS/RPBS |
Combination |
1.287 |
1.399 |
1.303 |
|
PBS/RPBS |
Total |
4.665 |
4.359 |
3.755 |
|
SURVEY |
Plain |
0.778 |
0.643 |
0.616 |
|
SURVEY |
Combination |
0.341 |
0.405 |
0.493 |
|
SURVEY |
Total |
1.119 |
1.048 |
1.109 |
|
FOSINOPRIL |
|||||
C09AA09 |
PBS/RPBS |
Plain |
1.347 |
1.226 |
1.070 |
PBS/RPBS |
Combination |
1.686 |
1.548 |
1.404 |
|
PBS/RPBS |
Total |
3.033 |
2.774 |
2.474 |
|
SURVEY |
Plain |
0.347 |
0.293 |
0.263 |
|
SURVEY |
Combination |
0.609 |
0.516 |
0.444 |
|
SURVEY |
Total |
0.956 |
0.809 |
0.707 |
|
LISINOPRIL |
|||||
C09AA03 |
PBS/RPBS |
Plain |
3.247 |
2.945 |
2.552 |
SURVEY |
Plain |
0.957 |
0.819 |
0.711 |
|
PERINDOPRIL |
|||||
C09AA04 |
PBS/RPBS |
Plain |
22.589 |
22.911 |
22.136 |
PBS/RPBS |
Combination |
6.064 |
6.740 |
8.988 |
|
PBS/RPBS |
Total |
28.653 |
29.651 |
31.124 |
|
SURVEY |
Plain |
9.143 |
8.850 |
8.334 |
|
SURVEY |
Combination |
2.545 |
2.326 |
2.795 |
|
SURVEY |
Total |
11.688 |
11.176 |
11.129 |
|
QUINAPRIL |
|||||
C09AA06 |
PBS/RPBS |
Plain |
1.334 |
1.134 |
1.005 |
PBS/RPBS |
Combination |
0.380 |
0.362 |
0.337 |
|
PBS/RPBS |
Total |
1.714 |
1.496 |
1.342 |
|
SURVEY |
Plain |
0.348 |
0.320 |
0.275 |
|
SURVEY |
Combination |
0.162 |
0.147 |
0.119 |
|
SURVEY |
Total |
0.510 |
0.467 |
0.394 |
|
RAMIPRIL |
|||||
C09AA05 |
PBS/RPBS |
Plain |
27.674 |
26.741 |
25.454 |
PBS/RPBS |
Combination |
0.390 |
0.452 |
0.456 |
|
PBS/RPBS |
Total |
28.064 |
27.193 |
25.910 |
|
SURVEY |
Plain |
10.402 |
9.461 |
8.617 |
|
SURVEY |
Combination |
0.206 |
0.208 |
0.198 |
|
SURVEY |
Total |
10.608 |
9.669 |
8.815 |
|
ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN |
|||||
TRANDOLAPRIL |
|||||
C09AA10 |
PBS/RPBS |
Plain |
1.516 |
1.379 |
1.236 |
PBS/RPBS |
Combination |
0.200 |
0.153 |
0.155 |
|
PBS/RPBS |
Total |
1.716 |
1.532 |
1.391 |
|
SURVEY |
Plain |
0.514 |
0.457 |
0.400 |
|
SURVEY |
Combination |
0.008 |
0.102 |
0.099 |
|
SURVEY |
Total |
0.522 |
0.559 |
0.499 |
|
ANGIOTENSIN II ANTAGONISTS |
|||||
ANGIOTENSIN II ANTAGONISTS PLAIN |
|||||
CANDESARTAN |
|||||
C09CA06 |
PBS/RPBS |
Plain |
15.599 |
16.800 |
17.246 |
PBS/RPBS |
Combination |
5.850 |
7.278 |
9.714 |
|
PBS/RPBS |
Total |
21.449 |
24.078 |
26.960 |
|
SURVEY |
Plain |
3.448 |
3.343 |
3.290 |
|
SURVEY |
Combination |
2.610 |
2.346 |
1.975 |
|
SURVEY |
Total |
6.058 |
5.689 |
5.265 |
|
EPROSARTAN |
|||||
C09CA02 |
PBS/RPBS |
Plain |
0.345 |
0.302 |
0.266 |
PBS/RPBS |
Combination |
0.293 |
0.231 |
0.209 |
|
PBS/RPBS |
Total |
0.638 |
0.533 |
0.475 |
|
SURVEY |
Plain |
0.097 |
0.082 |
0.069 |
|
SURVEY |
Combination |
0.051 |
0.085 |
0.066 |
|
SURVEY |
Total |
0.148 |
0.167 |
0.135 |
|
IRBESARTAN |
|||||
C09CA04 |
PBS/RPBS |
Plain |
16.699 |
16.378 |
16.013 |
PBS/RPBS |
Combination |
17.672 |
17.590 |
16.994 |
|
PBS/RPBS |
Total |
34.371 |
33.968 |
33.007 |
|
SURVEY |
Plain |
6.181 |
5.651 |
5.289 |
|
SURVEY |
Combination |
6.189 |
5.415 |
4.898 |
|
SURVEY |
Total |
12.370 |
11.066 |
10.187 |
|
LOSARTAN |
|||||
C09CA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.010 |
0.008 |
0.018 |
|
OLMESARTAN MEDOXOMIL |
|||||
C09CA08 |
PBS/RPBS |
Plain |
1.066 |
1.504 |
1.841 |
PBS/RPBS |
Combination |
1.207 |
1.753 |
2.463 |
|
PBS/RPBS |
Total |
2.273 |
3.257 |
4.304 |
|
SURVEY |
Plain |
0.666 |
0.955 |
1.122 |
|
SURVEY |
Combination |
0.307 |
0.454 |
0.506 |
|
SURVEY |
Total |
0.973 |
1.409 |
1.628 |
|
TELMISARTAN |
|||||
C09CA07 |
PBS/RPBS |
Plain |
8.143 |
8.778 |
9.296 |
ANGIOTENSIN II ANTAGONISTS |
|||||
PBS/RPBS |
Combination |
5.254 |
5.426 |
5.719 |
|
PBS/RPBS |
Total |
13.397 |
14.204 |
15.015 |
|
SURVEY |
Plain |
3.751 |
3.974 |
4.080 |
|
SURVEY |
Combination |
2.582 |
2.529 |
2.342 |
|
SURVEY |
Total |
6.333 |
6.503 |
6.422 |
|
VALSARTAN |
|||||
C09CA03 |
PBS/RPBS |
Plain |
0.064 |
0.285 |
0.426 |
PBS/RPBS |
Combination |
0.001 |
0.075 |
1.006 |
|
PBS/RPBS |
Total |
0.065 |
0.360 |
1.432 |
|
SURVEY |
Plain |
0.033 |
0.151 |
0.201 |
|
SURVEY |
Combination |
0.000 |
0.023 |
0.068 |
|
SURVEY |
Total |
0.033 |
0.174 |
0.269 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
CARDIOVASCULAR SYSTEM |
|||||
ATORVASTATIN |
|||||
C10AA05 |
PBS/RPBS |
Plain |
69.592 |
69.981 |
70.047 |
PBS/RPBS |
Combination |
10.218 |
13.664 |
14.995 |
|
PBS/RPBS |
Total |
79.810 |
83.645 |
85.042 |
|
SURVEY |
Plain |
0.172 |
0.104 |
0.116 |
|
SURVEY |
Combination |
0.016 |
0.016 |
0.022 |
|
SURVEY |
Total |
0.188 |
0.120 |
0.138 |
|
FLUVASTATIN |
|||||
C10AA04 |
PBS/RPBS |
Plain |
0.221 |
0.212 |
0.197 |
SURVEY |
Plain |
0.024 |
0.017 |
0.018 |
|
PRAVASTATIN |
|||||
C10AA03 |
PBS/RPBS |
Plain |
6.255 |
5.556 |
4.976 |
SURVEY |
Plain |
0.170 |
0.144 |
0.120 |
|
ROSUVASTATIN |
|||||
C10AA07 |
PBS/RPBS |
Plain |
21.926 |
29.765 |
36.158 |
SURVEY |
Plain |
0.043 |
0.056 |
0.066 |
|
SIMVASTATIN |
|||||
C10AA01 |
PBS/RPBS |
Plain |
22.114 |
20.006 |
18.272 |
PBS/RPBS |
Combination |
4.301 |
4.972 |
5.384 |
|
PBS/RPBS |
Total |
26.415 |
24.978 |
23.656 |
|
SURVEY |
Plain |
0.575 |
0.731 |
0.660 |
|
SURVEY |
Combination |
0.008 |
0.010 |
0.010 |
|
SURVEY |
Total |
0.583 |
0.741 |
0.670 |
|
FIBRATES |
|||||
FENOFIBRATE |
|||||
C10AB05 |
PBS/RPBS |
Plain |
1.393 |
1.611 |
1.821 |
SURVEY |
Plain |
0.019 |
0.021 |
0.021 |
|
GEMFIBROZIL |
|||||
C10AB04 |
PBS/RPBS |
Plain |
0.608 |
0.551 |
0.495 |
SURVEY |
Plain |
0.211 |
0.163 |
0.135 |
|
BILE ACID SEQUESTRANTS |
|||||
COLESTIPOL HYDROCHLORIDE |
|||||
C10AC02 |
PBS/RPBS |
Plain |
0.004 |
0.004 |
0.003 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
COLESTYRAMINE |
|||||
C10AC01 |
PBS/RPBS |
Plain |
0.120 |
0.122 |
0.123 |
SURVEY |
Plain |
0.004 |
0.002 |
0.001 |
|
NICOTINIC ACID AND DERIVATIVES |
|||||
NICOTINIC ACID |
|||||
C10AD02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
OTHER LIPID MODIFYING AGENTS |
|||||
LIPID MODIFYING AGENTS PLAIN |
|||||
EZETIMIBE |
|||||
C10AX09 |
PBS/RPBS |
Plain |
3.472 |
3.696 |
3.891 |
PBS/RPBS |
Combination |
2.203 |
2.599 |
2.890 |
|
PBS/RPBS |
Total |
5.675 |
6.295 |
6.781 |
|
SURVEY |
Plain |
0.018 |
0.014 |
0.015 |
|
SURVEY |
Combination |
0.004 |
0.005 |
0.008 |
|
SURVEY |
Total |
0.022 |
0.019 |
0.023 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
DERMATOLOGICALS |
|||||
GRISEOFULVIN |
|||||
D01BA01 |
PBS/RPBS |
Plain |
0.070 |
0.106 |
0.113 |
SURVEY |
Plain |
0.056 |
0.071 |
0.074 |
|
TERBINAFINE |
|||||
D01BA02 |
PBS/RPBS |
Plain |
0.451 |
0.434 |
0.430 |
SURVEY |
Plain |
0.061 |
0.055 |
0.057 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
DERMATOLOGICALS |
|||||
ACITRETIN |
|||||
D05BB02 |
PBS/RPBS |
Plain |
0.113 |
0.116 |
0.118 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
DERMATOLOGICALS |
|||||
ISOTRETINOIN |
|||||
D10BA01 |
PBS/RPBS |
Plain |
0.786 |
0.826 |
0.797 |
SURVEY |
Plain |
0.018 |
0.018 |
0.017 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||
CLINDAMYCIN |
|||||
G01AA10 |
SURVEY |
Plain |
0.017 |
0.019 |
0.022 |
NYSTATIN |
|||||
G01AA01 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.012 |
0.009 |
0.012 |
|
IMIDAZOLE DERIVATIVES |
|||||
BUTOCONAZOLE |
|||||
G01AF15 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
CLOTRIMAZOLE |
|||||
G01AF02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.016 |
0.012 |
0.013 |
|
ECONAZOLE NITRATE |
|||||
G01AF05 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
MICONAZOLE NITRATE |
|||||
G01AF04 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||
DINOPROSTONE |
|||||
G02AD02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
OTHER GYNAECOLOGICALS |
|||||
PROLACTIN INHIBITORS |
|||||
BROMOCRIPTINE MESYLATE |
|||||
G02CB01 |
PBS/RPBS |
Plain |
0.003 |
0.003 |
0.003 |
SURVEY |
Plain |
0.004 |
0.005 |
0.005 |
|
CABERGOLINE |
|||||
G02CB03 |
PBS/RPBS |
Plain |
0.035 |
0.036 |
0.037 |
SURVEY |
Plain |
0.002 |
0.002 |
0.002 |
|
QUINAGOLIDE |
|||||
G02CB04 |
PBS/RPBS |
Plain |
0.004 |
0.004 |
0.004 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||
ETONOGESTREL |
|||||
G03AC08 |
PBS/RPBS |
Plain |
9.232 |
9.812 |
10.800 |
SURVEY |
Plain |
0.275 |
0.059 |
0.130 |
|
MEDROXYPROGESTERONE |
|||||
G03AC06 |
PBS/RPBS |
Plain |
1.273 |
1.275 |
1.278 |
SURVEY |
Plain |
1.410 |
1.307 |
1.160 |
|
EMERGENCY CONTRACEPTIVES |
|||||
LEVONORGESTREL |
|||||
G03AD01 |
PBS/RPBS |
Plain |
0.401 |
0.395 |
0.364 |
SURVEY |
Plain |
1.279 |
1.250 |
1.343 |
|
ANDROGENS |
|||||
3-OXOANDROSTEN (4) DERIVATIVES |
|||||
TESTOSTERONE |
|||||
G03BA03 |
PBS/RPBS |
Plain |
0.716 |
0.773 |
0.798 |
SURVEY |
Plain |
0.162 |
0.169 |
0.197 |
|
5-ANDROSTANON (3) DERIVATIVES |
|||||
MESTEROLONE |
|||||
G03BB01 |
SURVEY |
Plain |
0.001 |
0.001 |
0.002 |
ESTROGENS |
|||||
NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN |
|||||
OESTRADIOL |
|||||
G03CA03 |
PBS/RPBS |
Plain |
1.495 |
1.486 |
1.569 |
SURVEY |
Plain |
1.250 |
1.220 |
1.227 |
|
OESTRADIOL VALERATE |
|||||
G03CA03 |
PBS/RPBS |
Plain |
0.508 |
0.685 |
0.653 |
SURVEY |
Plain |
0.472 |
0.512 |
0.466 |
|
OESTRIOL |
|||||
G03CA04 |
PBS/RPBS |
Plain |
2.243 |
2.266 |
1.734 |
SURVEY |
Plain |
1.003 |
0.986 |
0.761 |
|
OESTROGENS CONJUGATED |
|||||
G03CA57 |
PBS/RPBS |
Plain |
0.627 |
0.000 |
0.000 |
SURVEY |
Plain |
0.477 |
0.743 |
0.867 |
|
OESTRONE |
|||||
G03CA07 |
SURVEY |
Plain |
0.005 |
0.000 |
0.000 |
OTHER ESTROGENS |
|||||
TIBOLONE |
|||||
G03CX01 |
SURVEY |
Plain |
0.977 |
0.953 |
0.860 |
PROGESTOGENS |
|||||
PREGNEN (4) DERIVATIVES |
|||||
MEDROXYPROGESTERONE |
|||||
G03DA02 |
PBS/RPBS |
Plain |
0.625 |
0.592 |
0.552 |
PROGESTOGENS |
|||||
SURVEY |
Plain |
0.817 |
0.777 |
0.665 |
|
PROGESTERONE |
|||||
G03DA04 |
SURVEY |
Plain |
0.000 |
0.000 |
0.013 |
PREGNADIEN DERIVATIVES |
|||||
DYDROGESTERONE |
|||||
G03DB01 |
PBS/RPBS |
Plain |
0.014 |
0.015 |
0.001 |
SURVEY |
Plain |
0.025 |
0.024 |
0.002 |
|
ESTREN DERIVATIVES |
|||||
NORETHISTERONE |
|||||
G03DC02 |
PBS/RPBS |
Plain |
0.552 |
0.286 |
0.285 |
SURVEY |
Plain |
0.017 |
0.291 |
0.266 |
|
PROGESTOGENS AND ESTROGENS IN COMBINATION |
|||||
PROGESTOGENS AND ESTROGENS,SEQUENTIAL PREPARATIONS |
|||||
OESTRADIOL with NORETHISTERONE ACETATE |
|||||
G03FB05 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
|||||
GONADOTROPHINS |
|||||
CHORIOGONADOTROPIN ALFA |
|||||
G03GA08 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
FOLLITROPIN ALFA |
|||||
G03GA05 |
PBS/RPBS |
Plain |
0.005 |
0.006 |
0.006 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
FOLLITROPIN BETA |
|||||
G03GA06 |
PBS/RPBS |
Plain |
0.007 |
0.009 |
0.008 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
HUMAN CHORIONIC GONADOTROPHIN |
|||||
G03GA01 |
PBS/RPBS |
Plain |
0.023 |
0.024 |
0.010 |
SURVEY |
Plain |
0.002 |
0.003 |
0.002 |
|
OVULATION STIMULANTS, SYNTHETIC |
|||||
CLOMIPHENE CITRATE |
|||||
G03GB02 |
PBS/RPBS |
Plain |
0.148 |
0.258 |
0.264 |
SURVEY |
Plain |
0.111 |
0.017 |
0.018 |
|
ANTIANDROGENS |
|||||
ANTIANDROGENS, PLAIN PREPARATIONS |
|||||
CYPROTERONE ACETATE |
|||||
G03HA01 |
PBS/RPBS |
Plain |
0.378 |
0.347 |
0.308 |
SURVEY |
Plain |
0.009 |
0.005 |
0.007 |
|
OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
|||||
ANTIGONADOTROPINS AND SIMILAR AGENTS |
|||||
DANAZOL |
|||||
G03XA01 |
PBS/RPBS |
Plain |
0.007 |
0.006 |
0.006 |
SURVEY |
Plain |
0.000 |
0.001 |
0.001 |
|
OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
|||||
GESTRINONE |
|||||
G03XA02 |
PBS/RPBS |
Plain |
0.000 |
0.001 |
0.001 |
ANTIGONADOTROPINS AND SIMILAR AGENTS |
|||||
RALOXIFENE |
|||||
G03XC01 |
PBS/RPBS |
Plain |
0.930 |
0.830 |
0.739 |
SURVEY |
Plain |
0.046 |
0.036 |
0.032 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENITO URINARY SYSTEM AND SEX HORMONES |
|||||
DARIFENACIN |
|||||
G04BD10 |
SURVEY |
Plain |
0.012 |
0.026 |
0.045 |
OXYBUTYNIN |
|||||
G04BD04 |
PBS/RPBS |
Plain |
0.911 |
1.071 |
1.167 |
SURVEY |
Plain |
0.142 |
0.129 |
0.133 |
|
SOLIFENACIN |
|||||
G04BD08 |
SURVEY |
Plain |
0.563 |
0.617 |
0.695 |
TOLTERODINE |
|||||
G04BD07 |
SURVEY |
Plain |
0.025 |
0.030 |
0.034 |
DRUGS USED IN ERECTILE DYSFUNCTION |
|||||
ALPROSTADIL |
|||||
G04BE01 |
PBS/RPBS |
Plain |
0.002 |
0.002 |
0.002 |
SURVEY |
Plain |
0.034 |
0.038 |
0.044 |
|
SILDENAFIL |
|||||
G04BE03 |
PBS/RPBS |
Plain |
0.025 |
0.026 |
0.021 |
SURVEY |
Plain |
0.407 |
0.360 |
0.338 |
|
TADALAFIL |
|||||
G04BE08 |
PBS/RPBS |
Plain |
0.017 |
0.018 |
0.017 |
SURVEY |
Plain |
0.402 |
0.385 |
0.400 |
|
VARDENAFIL |
|||||
G04BE09 |
SURVEY |
Plain |
0.061 |
0.061 |
0.060 |
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
|||||
ALPHA-ADRENORECEPTOR ANTAGONISTS |
|||||
ALFUZOSIN |
|||||
G04CA01 |
SURVEY |
Plain |
0.000 |
0.009 |
0.030 |
TAMSULOSIN |
|||||
G04CA02 |
PBS/RPBS |
Plain |
0.184 |
0.199 |
0.204 |
PBS/RPBS |
Combination |
0.000 |
0.000 |
0.111 |
|
PBS/RPBS |
Total |
0.184 |
0.199 |
0.315 |
|
SURVEY |
Plain |
0.891 |
0.934 |
1.006 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.019 |
|
SURVEY |
Total |
0.891 |
0.934 |
1.025 |
|
TERAZOSIN |
|||||
G04CA03 |
PBS/RPBS |
Plain |
0.005 |
0.005 |
0.005 |
SURVEY |
Plain |
0.014 |
0.011 |
0.015 |
|
TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS |
|||||
DUTASTERIDE |
|||||
G04CB02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.085 |
PBS/RPBS |
Combination |
0.000 |
0.000 |
0.111 |
|
PBS/RPBS |
Total |
0.000 |
0.000 |
0.196 |
|
SURVEY |
Plain |
0.001 |
0.041 |
0.068 |
|
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
|||||
SURVEY |
Combination |
0.000 |
0.000 |
0.019 |
|
SURVEY |
Total |
0.001 |
0.041 |
0.087 |
|
FINASTERIDE |
|||||
G04CB01 |
PBS/RPBS |
Plain |
0.057 |
0.056 |
0.052 |
SURVEY |
Plain |
0.193 |
0.172 |
0.195 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES |
|||||
TETRACOSACTRIN |
|||||
H01AA02 |
PBS/RPBS |
Plain |
0.001 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
SOMATROPIN AND ANALOGUES |
|||||
SOMATROPIN |
|||||
H01AC01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
POSTERIOR PITUITARY LOBE HORMONES |
|||||
VASOPRESSIN AND ANALOGUES |
|||||
DESMOPRESSIN |
|||||
H01BA02 |
PBS/RPBS |
Plain |
0.270 |
0.269 |
0.274 |
SURVEY |
Plain |
0.010 |
0.010 |
0.011 |
|
OXYTOCIN AND ANALOGUES |
|||||
OXYTOCIN |
|||||
H01BB02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
HYPOTHALAMIC HORMONES |
|||||
GONADOTROPHIN-RELEASING HORMONES |
|||||
NAFARELIN |
|||||
H01CA02 |
PBS/RPBS |
Plain |
0.005 |
0.004 |
0.004 |
SURVEY |
Plain |
0.011 |
0.010 |
0.008 |
|
SOMATOSTATIN AND ANALOGUES |
|||||
LANREOTIDE |
|||||
H01CB03 |
PBS/RPBS |
Plain |
0.006 |
0.008 |
0.009 |
OCTREOTIDE |
|||||
H01CB02 |
PBS/RPBS |
Plain |
0.012 |
0.014 |
0.016 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ANTI-GONADOTROPIN-RELEASING HORMONES |
|||||
GANIRELIX |
|||||
H01CC01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES |
|||||
FLUDROCORTISONE ACETATE |
|||||
H02AA02 |
PBS/RPBS |
Plain |
0.432 |
0.514 |
0.625 |
SURVEY |
Plain |
0.241 |
0.184 |
0.092 |
|
GLUCOCORTICOIDS |
|||||
BETAMETHASONE |
|||||
H02AB01 |
PBS/RPBS |
Plain |
0.129 |
0.117 |
0.066 |
SURVEY |
Plain |
0.049 |
0.042 |
0.026 |
|
BUDESONIDE |
|||||
H02AB16 |
SURVEY |
Plain |
0.008 |
0.010 |
0.011 |
CORTISONE |
|||||
H02AB10 |
PBS/RPBS |
Plain |
0.127 |
0.126 |
0.120 |
SURVEY |
Plain |
0.065 |
0.061 |
0.060 |
|
DEXAMETHASONE |
|||||
H02AB02 |
PBS/RPBS |
Plain |
0.829 |
0.785 |
0.790 |
SURVEY |
Plain |
0.255 |
0.268 |
0.263 |
|
HYDROCORTISONE |
|||||
H02AB09 |
PBS/RPBS |
Plain |
0.104 |
0.113 |
0.120 |
SURVEY |
Plain |
0.054 |
0.054 |
0.061 |
|
METHYLPREDNISOLONE |
|||||
H02AB04 |
PBS/RPBS |
Plain |
0.089 |
0.085 |
0.089 |
SURVEY |
Plain |
0.016 |
0.016 |
0.017 |
|
PREDNISOLONE |
|||||
H02AB06 |
PBS/RPBS |
Plain |
5.292 |
5.568 |
5.667 |
SURVEY |
Plain |
3.883 |
4.163 |
4.171 |
|
PREDNISONE |
|||||
H02AB07 |
PBS/RPBS |
Plain |
2.100 |
2.120 |
2.193 |
SURVEY |
Plain |
1.336 |
1.334 |
1.377 |
|
TRIAMCINOLONE ACETONIDE |
|||||
H02AB08 |
PBS/RPBS |
Plain |
0.003 |
0.005 |
0.014 |
SURVEY |
Plain |
0.003 |
0.004 |
0.011 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES |
|||||
LEVOTHYROXINE SODIUM |
|||||
H03AA01 |
PBS/RPBS |
Plain |
10.302 |
10.473 |
10.630 |
SURVEY |
Plain |
6.142 |
5.979 |
6.158 |
|
LIOTHYRONINE |
|||||
H03AA02 |
PBS/RPBS |
Plain |
0.048 |
0.049 |
0.053 |
SURVEY |
Plain |
0.003 |
0.003 |
0.004 |
|
ANTITHYROID PREPARATIONS |
|||||
THIOURACILS |
|||||
PROPYLTHIOURACIL |
|||||
H03BA02 |
PBS/RPBS |
Plain |
0.205 |
0.203 |
0.186 |
SURVEY |
Plain |
0.007 |
0.005 |
0.006 |
|
SULPHUR-CONTAINING IMIDAZOLE DERIVATIVES |
|||||
CARBIMAZOLE |
|||||
H03BB01 |
PBS/RPBS |
Plain |
0.383 |
0.425 |
0.466 |
SURVEY |
Plain |
0.266 |
0.290 |
0.293 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES |
|||||
GLUCAGON HYDROCHLORIDE |
|||||
H04AA01 |
PBS/RPBS |
Plain |
0.006 |
0.006 |
0.007 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
SYSTEMIC HORMONAL PREP EXCL.SEX HORMONES |
|||||
TERIPARATIDE (RBE) |
|||||
H05AA02 |
PBS/RPBS |
Plain |
0.005 |
0.020 |
0.024 |
SURVEY |
Plain |
0.002 |
0.004 |
0.001 |
|
ANTI-PARATHYROID AGENTS |
|||||
CALCITONIN PREPARATIONS |
|||||
CALCITONIN (SALMON SYNTHETIC) |
|||||
H05BA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER ANTI-PARATHYROID AGENTS |
|||||
CINACALCET |
|||||
H05BX01 |
PBS/RPBS |
Plain |
0.024 |
0.037 |
0.044 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE |
|||||
DOXYCYCLINE |
|||||
J01AA02 |
PBS/RPBS |
Plain |
1.109 |
1.144 |
1.177 |
SURVEY |
Plain |
1.428 |
1.428 |
1.419 |
|
MINOCYCLINE |
|||||
J01AA08 |
PBS/RPBS |
Plain |
0.234 |
0.235 |
0.229 |
SURVEY |
Plain |
0.521 |
0.498 |
0.465 |
|
BETA-LACTAM ANTIBACTERIALS,PENICILLINS |
|||||
PENICILLINS WITH EXTENDED SPECTRUM |
|||||
AMOXYCILLIN |
|||||
J01CA04 |
PBS/RPBS |
Plain |
2.587 |
2.649 |
2.667 |
SURVEY |
Plain |
3.645 |
3.678 |
3.537 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
3.645 |
3.678 |
3.537 |
|
AMPICILLIN |
|||||
J01CA01 |
PBS/RPBS |
Plain |
0.003 |
0.003 |
0.003 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
BETA-LACTAMASE SENSITIVE PENICILLINS |
|||||
BENZATHINE PENICILLIN |
|||||
J01CE08 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
BENZATHINE PHENOXYMETHYLPENICILLIN |
|||||
J01CE10 |
PBS/RPBS |
Plain |
0.017 |
0.020 |
0.018 |
SURVEY |
Plain |
0.033 |
0.039 |
0.036 |
|
BENZYLPENICILLIN |
|||||
J01CE01 |
PBS/RPBS |
Plain |
0.006 |
0.006 |
0.004 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
PHENOXYMETHYLPENICILLIN |
|||||
J01CE02 |
PBS/RPBS |
Plain |
0.190 |
0.193 |
0.186 |
SURVEY |
Plain |
0.454 |
0.458 |
0.441 |
|
PROCAINE PENICILLIN |
|||||
J01CE09 |
PBS/RPBS |
Plain |
0.017 |
0.015 |
0.014 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
BETA-LACTAMASE RESISTANT PENICILLINS |
|||||
DICLOXACILLIN |
|||||
J01CF01 |
PBS/RPBS |
Plain |
0.145 |
0.146 |
0.142 |
SURVEY |
Plain |
0.150 |
0.148 |
0.133 |
|
FLUCLOXACILLIN |
|||||
J01CF05 |
PBS/RPBS |
Plain |
0.200 |
0.213 |
0.227 |
SURVEY |
Plain |
0.201 |
0.217 |
0.216 |
|
COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS |
|||||
AMOXYCILLIN with CLAVULANIC ACID |
|||||
BETA-LACTAM ANTIBACTERIALS,PENICILLINS |
|||||
J01CR02 |
PBS/RPBS |
Plain |
1.778 |
1.895 |
2.036 |
SURVEY |
Plain |
2.151 |
2.183 |
2.317 |
|
TICARCILLIN with CLAVULANIC ACID |
|||||
J01CR03 |
PBS/RPBS |
Plain |
0.008 |
0.009 |
0.009 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER BETA-LACTAM ANTIBACTERIALS |
|||||
FIRST-GENERATION CEPHALOSPORINS |
|||||
CEFALEXIN |
|||||
J01DB01 |
PBS/RPBS |
Plain |
1.477 |
1.562 |
1.599 |
SURVEY |
Plain |
1.237 |
1.263 |
1.350 |
|
CEFALOTHIN |
|||||
J01DB03 |
PBS/RPBS |
Plain |
0.013 |
0.009 |
0.005 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
CEPHAZOLIN |
|||||
J01DB04 |
PBS/RPBS |
Plain |
0.010 |
0.013 |
0.016 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
SECOND-GENERATION CEPHALOSPORINS |
|||||
CEFACLOR |
|||||
J01DC04 |
PBS/RPBS |
Plain |
0.203 |
0.189 |
0.179 |
SURVEY |
Plain |
0.281 |
0.270 |
0.245 |
|
CEFUROXIME |
|||||
J01DC02 |
PBS/RPBS |
Plain |
0.053 |
0.055 |
0.056 |
SURVEY |
Plain |
0.051 |
0.050 |
0.053 |
|
THIRD-GENERATION CEPHALOSPORINS |
|||||
CEFOTAXIME |
|||||
J01DD01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
CEFTAZIDIME |
|||||
J01DD02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
CEFTRIAXONE |
|||||
J01DD04 |
PBS/RPBS |
Plain |
0.018 |
0.018 |
0.018 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
|
FOUTH-GENERATION CEPHALOSPORINS |
|||||
CEFEPIME |
|||||
J01DE01 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
CARBAPENEMS |
|||||
MEROPENEM |
|||||
J01DH02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
SULFONAMIDES AND TRIMETHOPRIM |
|||||
TRIMETHOPRIM AND DERIVATIVES |
|||||
TRIMETHOPRIM |
|||||
SULFONAMIDES AND TRIMETHOPRIM |
|||||
J01EA01 |
PBS/RPBS |
Plain |
0.357 |
0.365 |
0.365 |
SURVEY |
Plain |
0.210 |
0.205 |
0.205 |
|
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
|||||
MACROLIDES |
|||||
AZITHROMYCIN |
|||||
J01FA10 |
PBS/RPBS |
Plain |
0.016 |
0.019 |
0.023 |
SURVEY |
Plain |
0.092 |
0.109 |
0.127 |
|
CLARITHROMYCIN |
|||||
J01FA09 |
PBS/RPBS |
Plain |
0.367 |
0.403 |
0.475 |
SURVEY |
Plain |
0.448 |
0.474 |
0.557 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
0.448 |
0.474 |
0.557 |
|
ERYTHROMYCIN |
|||||
J01FA01 |
PBS/RPBS |
Plain |
0.439 |
0.450 |
0.467 |
SURVEY |
Plain |
0.648 |
0.649 |
0.670 |
|
ROXITHROMYCIN |
|||||
J01FA06 |
PBS/RPBS |
Plain |
0.768 |
0.766 |
0.736 |
SURVEY |
Plain |
0.770 |
0.729 |
0.695 |
|
LINCOSAMIDES |
|||||
CLINDAMYCIN |
|||||
J01FF01 |
PBS/RPBS |
Plain |
0.076 |
0.086 |
0.093 |
SURVEY |
Plain |
0.043 |
0.044 |
0.039 |
|
LINCOMYCIN |
|||||
J01FF02 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
AMINOGLYCOSIDE ANTIBACTERIALS |
|||||
OTHER AMINOGLYCOSIDES |
|||||
GENTAMICIN SULPHATE |
|||||
J01GB03 |
PBS/RPBS |
Plain |
0.008 |
0.007 |
0.007 |
SURVEY |
Plain |
0.001 |
0.001 |
0.002 |
|
NEOMYCIN |
|||||
J01GB05 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
TOBRAMYCIN |
|||||
J01GB01 |
PBS/RPBS |
Plain |
0.003 |
0.003 |
0.006 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
QUINOLONE ANTIBACTERIALS |
|||||
FLUOROQUINOLONES |
|||||
CIPROFLOXACIN |
|||||
J01MA02 |
PBS/RPBS |
Plain |
0.258 |
0.269 |
0.282 |
SURVEY |
Plain |
0.032 |
0.038 |
0.043 |
|
MOXIFLOXACIN |
|||||
J01MA14 |
SURVEY |
Plain |
0.002 |
0.003 |
0.004 |
QUINOLONE ANTIBACTERIALS |
|||||
NORFLOXACIN |
|||||
J01MA06 |
PBS/RPBS |
Plain |
0.148 |
0.148 |
0.145 |
SURVEY |
Plain |
0.116 |
0.118 |
0.124 |
|
OTHER ANTIBACTERIALS |
|||||
GLYCOPEPTIDE ANTIBACTERIALS |
|||||
VANCOMYCIN |
|||||
J01XA01 |
PBS/RPBS |
Plain |
0.007 |
0.007 |
0.007 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
STEROID ANTIBACTERIALS |
|||||
FUSIDIC ACID |
|||||
J01XC01 |
PBS/RPBS |
Plain |
0.034 |
0.034 |
0.035 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
IMIDAZOLE DERIVATIVES |
|||||
METRONIDAZOLE |
|||||
J01XD01 |
PBS/RPBS |
Plain |
0.003 |
0.003 |
0.003 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
NITROFURAN DERIVATIVES |
|||||
NITROFURANTOIN |
|||||
J01XE01 |
PBS/RPBS |
Plain |
0.184 |
0.191 |
0.190 |
SURVEY |
Plain |
0.049 |
0.049 |
0.055 |
|
OTHER ANTIBACTERIALS |
|||||
HEXAMINE HIPPURATE |
|||||
J01XX05 |
PBS/RPBS |
Plain |
0.499 |
0.542 |
0.601 |
SURVEY |
Plain |
0.002 |
0.002 |
0.002 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE |
|||||
AMPHOTERICIN |
|||||
J02AA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
IMIDAZOLE DERIVATIVES |
|||||
KETOCONAZOLE |
|||||
J02AB02 |
PBS/RPBS |
Plain |
0.081 |
0.073 |
0.079 |
SURVEY |
Plain |
0.053 |
0.050 |
0.043 |
|
TRIAZOLE DERIVATIVES |
|||||
FLUCONAZOLE |
|||||
J02AC01 |
PBS/RPBS |
Plain |
0.060 |
0.068 |
0.079 |
SURVEY |
Plain |
0.004 |
0.004 |
0.008 |
|
ITRACONAZOLE |
|||||
J02AC02 |
PBS/RPBS |
Plain |
0.028 |
0.029 |
0.030 |
SURVEY |
Plain |
0.005 |
0.010 |
0.013 |
|
POSACONAZOLE |
|||||
J02AC04 |
PBS/RPBS |
Plain |
0.003 |
0.004 |
0.006 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
VORICONAZOLE |
|||||
J02AC03 |
PBS/RPBS |
Plain |
0.006 |
0.010 |
0.012 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE |
|||||
RIFABUTIN |
|||||
J04AB04 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
|
RIFAMPICIN |
|||||
J04AB02 |
PBS/RPBS |
Plain |
0.007 |
0.007 |
0.006 |
SURVEY |
Plain |
0.013 |
0.012 |
0.012 |
|
HYDRAZIDES |
|||||
ISONIAZID |
|||||
J04AC01 |
PBS/RPBS |
Plain |
0.005 |
0.005 |
0.004 |
SURVEY |
Plain |
0.002 |
0.003 |
0.003 |
|
OTHER DRUGS FOR TREATMENT OF TUBERCULOSIS |
|||||
ETHAMBUTOL HYDROCHLORIDE |
|||||
J04AK02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
DRUGS FOR TREATMENT OF LEPRA |
|||||
DRUGS FOR TREATMENT OF LEPRA |
|||||
DAPSONE |
|||||
J04BA02 |
PBS/RPBS |
Plain |
0.084 |
0.089 |
0.095 |
SURVEY |
Plain |
0.001 |
0.000 |
0.002 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE |
|||||
ACICLOVIR |
|||||
J05AB01 |
PBS/RPBS |
Plain |
0.024 |
0.023 |
0.023 |
SURVEY |
Plain |
0.004 |
0.004 |
0.004 |
|
CIDOFOVIR |
|||||
J05AB12 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
FAMCICLOVIR |
|||||
J05AB09 |
PBS/RPBS |
Plain |
0.258 |
0.272 |
0.289 |
SURVEY |
Plain |
0.024 |
0.025 |
0.033 |
|
GANCICLOVIR |
|||||
J05AB06 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
VALACICLOVIR |
|||||
J05AB11 |
PBS/RPBS |
Plain |
0.255 |
0.268 |
0.282 |
SURVEY |
Plain |
0.008 |
0.009 |
0.011 |
|
VALGANCICLOVIR |
|||||
J05AB14 |
PBS/RPBS |
Plain |
0.000 |
0.001 |
0.001 |
PHOSPHONIC ACID DERIVATIVES |
|||||
FOSCARNET |
|||||
J05AD01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
PROTEINASE INHIBITORS |
|||||
ATAZANAVIR |
|||||
J05AE08 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
DARUNAVIR |
|||||
J05AE10 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
INDINAVIR |
|||||
J05AE02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
RITONAVIR |
|||||
J05AE03 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SAQUINAVIR |
|||||
J05AE01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS |
|||||
ABACAVIR |
|||||
J05AF06 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ADEFOVIR DIPIVOXIL |
|||||
J05AF08 |
PBS/RPBS |
Plain |
0.025 |
0.017 |
0.012 |
SURVEY |
Plain |
0.001 |
0.002 |
0.002 |
|
DIDANOSINE |
|||||
J05AF02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.001 |
0.001 |
0.000 |
|
ENTECAVIR |
|||||
J05AF10 |
PBS/RPBS |
Plain |
0.074 |
0.095 |
0.109 |
DIRECT ACTING ANTIVIRALS |
|||||
SURVEY |
Plain |
0.001 |
0.002 |
0.002 |
|
LAMIVUDINE |
|||||
J05AF05 |
PBS/RPBS |
Plain |
0.011 |
0.009 |
0.008 |
SURVEY |
Plain |
0.002 |
0.002 |
0.003 |
|
STAVUDINE |
|||||
J05AF04 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
TELBIVUDINE |
|||||
J05AF11 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
TENOFOVIR |
|||||
J05AF07 |
PBS/RPBS |
Plain |
0.001 |
0.025 |
0.047 |
SURVEY |
Plain |
0.002 |
0.021 |
0.024 |
|
ZIDOVUDINE |
|||||
J05AF01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS |
|||||
EFAVIRENZ |
|||||
J05AG03 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
ETRAVIRINE |
|||||
J05AG04 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
NEVIRAPINE |
|||||
J05AG01 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.019 |
0.023 |
0.031 |
|
NEURAMINIDASE INHIBITORS |
|||||
OSELTAMIVIR |
|||||
J05AH02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ZANAMIVIR |
|||||
J05AH01 |
SURVEY |
Plain |
0.005 |
0.001 |
0.002 |
OTHER ANTIVIRALS |
|||||
RALTEGRAVIR |
|||||
J05AX08 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||
MEDROXYPROGESTERONE |
|||||
L02AB02 |
PBS/RPBS |
Plain |
0.005 |
0.005 |
0.005 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
MEGESTROL |
|||||
L02AB01 |
PBS/RPBS |
Plain |
0.005 |
0.005 |
0.005 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
GONADOTROPHIN RELEASING HORMONE ANALOGUES |
|||||
GOSERELIN |
|||||
L02AE03 |
PBS/RPBS |
Plain |
0.595 |
0.595 |
0.601 |
SURVEY |
Plain |
0.004 |
0.003 |
0.002 |
|
LEUPRORELIN ACETATE |
|||||
L02AE02 |
PBS/RPBS |
Plain |
0.836 |
0.828 |
0.813 |
SURVEY |
Plain |
0.002 |
0.003 |
0.040 |
|
TRIPTORELIN |
|||||
L02AE04 |
PBS/RPBS |
Plain |
0.000 |
0.001 |
0.005 |
HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||
ANTI-ESTROGENS |
|||||
FULVESTRANT |
|||||
L02BA03 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
TAMOXIFEN |
|||||
L02BA01 |
PBS/RPBS |
Plain |
0.917 |
0.889 |
0.904 |
SURVEY |
Plain |
0.009 |
0.010 |
0.013 |
|
TOREMIFENE |
|||||
L02BA02 |
PBS/RPBS |
Plain |
0.008 |
0.006 |
0.006 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ANTI-ANDROGENS |
|||||
BICALUTAMIDE |
|||||
L02BB03 |
PBS/RPBS |
Plain |
0.128 |
0.126 |
0.134 |
SURVEY |
Plain |
0.002 |
0.001 |
0.001 |
|
FLUTAMIDE |
|||||
L02BB01 |
PBS/RPBS |
Plain |
0.011 |
0.010 |
0.008 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
NILUTAMIDE |
|||||
L02BB02 |
PBS/RPBS |
Plain |
0.091 |
0.090 |
0.088 |
AROMATASE INHIBITORS |
|||||
ANASTROZOLE |
|||||
L02BG03 |
PBS/RPBS |
Plain |
0.779 |
0.802 |
0.791 |
SURVEY |
Plain |
0.001 |
0.003 |
0.003 |
|
EXEMESTANE |
|||||
L02BG06 |
PBS/RPBS |
Plain |
0.078 |
0.083 |
0.089 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
|
HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||
LETROZOLE |
|||||
L02BG04 |
PBS/RPBS |
Plain |
0.412 |
0.471 |
0.504 |
SURVEY |
Plain |
0.006 |
0.005 |
0.008 |
|
OTHER HORMONE ANTAGONISTS AND RELATED AGENTS |
|||||
DEGARELIX |
|||||
L02BX02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.004 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||
FILGRASTIM |
|||||
L03AA02 |
PBS/RPBS |
Plain |
0.006 |
0.006 |
0.006 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
LENOGRASTIM |
|||||
L03AA10 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
PEGFILGRASTIM |
|||||
L03AA13 |
PBS/RPBS |
Plain |
0.042 |
0.042 |
0.044 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
INTERFERONS |
|||||
INTERFERON BETA-1a |
|||||
L03AB07 |
PBS/RPBS |
Plain |
0.349 |
0.370 |
0.361 |
SURVEY |
Plain |
0.003 |
0.001 |
0.001 |
|
INTERFERON BETA-1b |
|||||
L03AB08 |
PBS/RPBS |
Plain |
0.123 |
0.119 |
0.106 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
|
INTERFERON-ALFA-2a |
|||||
L03AB04 |
PBS/RPBS |
Plain |
0.006 |
0.006 |
0.005 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
INTERFERON-ALFA-2b |
|||||
L03AB05 |
PBS/RPBS |
Plain |
0.004 |
0.004 |
0.005 |
INTERFERON-GAMMA |
|||||
L03AB03 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
PEGINTERFERON ALFA-2a |
|||||
L03AB11 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
PEGINTERFERON ALFA-2b |
|||||
L03AB10 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
OTHER IMMUNOSTIMULANTS |
|||||
GLATIRAMER ACETATE |
|||||
L03AX13 |
PBS/RPBS |
Plain |
0.080 |
0.088 |
0.091 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
|||||
ABATACEPT |
|||||
L04AA24 |
PBS/RPBS |
Plain |
0.015 |
0.021 |
0.014 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
EFALIZUMAB |
|||||
L04AA21 |
PBS/RPBS |
Plain |
0.009 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
EVEROLIMUS |
|||||
L04AA18 |
PBS/RPBS |
Plain |
0.004 |
0.006 |
0.008 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
FINGOLIMOD |
|||||
L04AA27 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.018 |
LEFLUNOMIDE |
|||||
L04AA13 |
PBS/RPBS |
Plain |
0.564 |
0.574 |
0.566 |
SURVEY |
Plain |
0.001 |
0.001 |
0.004 |
|
MYCOPHENOLIC ACID |
|||||
L04AA06 |
PBS/RPBS |
Plain |
0.051 |
0.060 |
0.067 |
SURVEY |
Plain |
0.003 |
0.004 |
0.003 |
|
NATALIZUMAB |
|||||
L04AA23 |
PBS/RPBS |
Plain |
0.012 |
0.015 |
0.018 |
SIROLIMUS |
|||||
L04AA10 |
PBS/RPBS |
Plain |
0.004 |
0.004 |
0.004 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
TUMOR NECROSIS FACTOR ALPHA INHIBITORS |
|||||
ADALIMUMAB |
|||||
L04AB04 |
PBS/RPBS |
Plain |
0.263 |
0.322 |
0.364 |
SURVEY |
Plain |
0.000 |
0.001 |
0.001 |
|
CERTOLIZUMAB PEGOL |
|||||
L04AB05 |
PBS/RPBS |
Plain |
0.000 |
0.001 |
0.014 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
ETANERCEPT |
|||||
L04AB01 |
PBS/RPBS |
Plain |
0.219 |
0.248 |
0.250 |
SURVEY |
Plain |
0.001 |
0.000 |
0.001 |
|
GOLIMUMAB |
|||||
L04AB06 |
PBS/RPBS |
Plain |
0.000 |
0.012 |
0.058 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
INFLIXIMAB |
|||||
L04AB02 |
PBS/RPBS |
Plain |
0.187 |
0.163 |
0.080 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
|
INTERLEUKIN INHIBITORS |
|||||
ANAKINRA |
|||||
L04AC03 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.000 |
IMMUNOSUPPRESSANTS |
|||||
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
TOCILIZUMAB |
|||||
L04AC07 |
PBS/RPBS |
Plain |
0.000 |
0.008 |
0.025 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
USTEKINUMAB |
|||||
L04AC05 |
PBS/RPBS |
Plain |
0.000 |
0.020 |
0.040 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
CALCINEURIN INHIBITORS |
|||||
CYCLOSPORIN |
|||||
L04AD01 |
PBS/RPBS |
Plain |
0.080 |
0.083 |
0.075 |
SURVEY |
Plain |
0.004 |
0.005 |
0.006 |
|
TACROLIMUS |
|||||
L04AD02 |
PBS/RPBS |
Plain |
0.042 |
0.052 |
0.057 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER IMMUNOSUPPRESSANTS |
|||||
AZATHIOPRINE |
|||||
L04AX01 |
PBS/RPBS |
Plain |
0.572 |
0.607 |
0.643 |
SURVEY |
Plain |
0.004 |
0.004 |
0.012 |
|
LENALIDOMIDE |
|||||
L04AX04 |
PBS/RPBS |
Plain |
0.002 |
0.016 |
0.011 |
THALIDOMIDE |
|||||
L04AX02 |
PBS/RPBS |
Plain |
0.010 |
0.014 |
0.018 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
MUSCULO-SKELETAL SYSTEM |
|||||
DICLOFENAC |
|||||
M01AB05 |
PBS/RPBS |
Plain |
1.994 |
1.787 |
1.552 |
PBS/RPBS |
Combination |
0.003 |
0.002 |
0.002 |
|
PBS/RPBS |
Total |
1.997 |
1.789 |
1.554 |
|
SURVEY |
Plain |
1.727 |
1.552 |
1.409 |
|
SURVEY |
Combination |
0.002 |
0.003 |
0.002 |
|
SURVEY |
Total |
1.729 |
1.555 |
1.411 |
|
INDOMETHACIN |
|||||
M01AB01 |
PBS/RPBS |
Plain |
0.618 |
0.602 |
0.575 |
SURVEY |
Plain |
0.582 |
0.549 |
0.541 |
|
KETOROLAC |
|||||
M01AB15 |
SURVEY |
Plain |
0.002 |
0.002 |
0.003 |
SULINDAC |
|||||
M01AB02 |
PBS/RPBS |
Plain |
0.033 |
0.030 |
0.016 |
SURVEY |
Plain |
0.012 |
0.011 |
0.004 |
|
OXICAMS |
|||||
MELOXICAM |
|||||
M01AC06 |
PBS/RPBS |
Plain |
5.606 |
5.473 |
5.195 |
SURVEY |
Plain |
2.226 |
2.207 |
2.140 |
|
PIROXICAM |
|||||
M01AC01 |
PBS/RPBS |
Plain |
0.483 |
0.424 |
0.366 |
SURVEY |
Plain |
0.266 |
0.236 |
0.201 |
|
PROPIONIC ACID DERIVATIVES |
|||||
IBUPROFEN |
|||||
M01AE01 |
PBS/RPBS |
Plain |
0.712 |
0.664 |
0.623 |
SURVEY |
Plain |
0.388 |
0.356 |
0.327 |
|
SURVEY |
Combination |
0.069 |
0.094 |
0.088 |
|
SURVEY |
Total |
0.457 |
0.450 |
0.415 |
|
KETOPROFEN |
|||||
M01AE03 |
PBS/RPBS |
Plain |
0.522 |
0.458 |
0.398 |
SURVEY |
Plain |
0.240 |
0.221 |
0.181 |
|
NAPROXEN |
|||||
M01AE02 |
PBS/RPBS |
Plain |
2.109 |
2.006 |
1.985 |
SURVEY |
Plain |
1.691 |
1.599 |
1.569 |
|
TIAPROFENIC ACID |
|||||
M01AE11 |
PBS/RPBS |
Plain |
0.030 |
0.026 |
0.022 |
SURVEY |
Plain |
0.008 |
0.008 |
0.008 |
|
FENAMATES |
|||||
MEFENAMIC ACID |
|||||
M01AG01 |
PBS/RPBS |
Plain |
0.037 |
0.038 |
0.038 |
SURVEY |
Plain |
0.035 |
0.036 |
0.034 |
|
ANTIINFLAMMATORY/ANTIRHEUMATIC PRODDUCTS,NON-STEROIDS |
|||||
COXIBS |
|||||
CELECOXIB |
|||||
M01AH01 |
PBS/RPBS |
Plain |
4.728 |
4.431 |
4.243 |
SURVEY |
Plain |
1.438 |
1.379 |
1.388 |
|
ETORICOXIB |
|||||
M01AH05 |
SURVEY |
Plain |
0.000 |
0.033 |
0.050 |
SPECIFIC ANTIRHEUMATIC AGENTS |
|||||
GOLD PREPARATIONS |
|||||
AURANOFIN |
|||||
M01CB03 |
PBS/RPBS |
Plain |
0.011 |
0.010 |
0.009 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
SODIUM AUROTHIOMALATE |
|||||
M01CB01 |
PBS/RPBS |
Plain |
0.046 |
0.039 |
0.038 |
SURVEY |
Plain |
0.001 |
0.000 |
0.001 |
|
PENICILLAMINE |
|||||
PENICILLAMINE |
|||||
M01CC01 |
PBS/RPBS |
Plain |
0.031 |
0.030 |
0.028 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
MUSCULO-SKELETAL SYSTEM |
|||||
ORPHENADRINE CITRATE |
|||||
M03BC01 |
SURVEY |
Plain |
0.057 |
0.073 |
0.097 |
ORPHENADRINE CITRATE with PARACETAMOL |
|||||
M03BC51 |
SURVEY |
Plain |
0.008 |
0.022 |
0.038 |
OTHER CENTRALLY ACTING AGENTS |
|||||
BACLOFEN |
|||||
M03BX01 |
PBS/RPBS |
Plain |
0.560 |
0.576 |
0.590 |
SURVEY |
Plain |
0.047 |
0.051 |
0.056 |
|
MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
|||||
DANTROLENE AND DERIVATIVES |
|||||
DANTROLENE SODIUM |
|||||
M03CA01 |
PBS/RPBS |
Plain |
0.033 |
0.033 |
0.033 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
MUSCULO-SKELETAL SYSTEM |
|||||
ALLOPURINOL |
|||||
M04AA01 |
PBS/RPBS |
Plain |
4.594 |
4.579 |
4.546 |
SURVEY |
Plain |
1.893 |
1.807 |
1.767 |
|
PREPARATIONS INCREASING URIC ACID EXCRETION |
|||||
PROBENECID |
|||||
M04AB01 |
PBS/RPBS |
Plain |
0.113 |
0.113 |
0.113 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
|
PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM |
|||||
COLCHICINE |
|||||
M04AC01 |
PBS/RPBS |
Plain |
1.033 |
1.988 |
16.489 |
SURVEY |
Plain |
0.514 |
0.833 |
7.332 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
MUSCULO-SKELETAL SYSTEM |
|||||
ALENDRONIC ACID |
|||||
M05BA04 |
PBS/RPBS |
Plain |
3.384 |
2.570 |
2.036 |
PBS/RPBS |
Combination |
3.279 |
3.367 |
3.338 |
|
PBS/RPBS |
Total |
6.663 |
5.937 |
5.374 |
|
SURVEY |
Plain |
0.119 |
0.084 |
0.073 |
|
SURVEY |
Combination |
0.069 |
0.059 |
0.055 |
|
SURVEY |
Total |
0.188 |
0.143 |
0.128 |
|
CLODRONIC ACID |
|||||
M05BA02 |
PBS/RPBS |
Plain |
0.055 |
0.048 |
0.040 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
DISODIUM ETIDRONATE |
|||||
M05BA01 |
PBS/RPBS |
Plain |
0.001 |
0.002 |
0.001 |
PBS/RPBS |
Combination |
0.016 |
0.012 |
0.010 |
|
PBS/RPBS |
Total |
0.017 |
0.014 |
0.011 |
|
SURVEY |
Plain |
0.001 |
0.001 |
0.000 |
|
SURVEY |
Combination |
0.001 |
0.001 |
0.000 |
|
SURVEY |
Total |
0.002 |
0.002 |
0.000 |
|
DISODIUM PAMIDRONATE |
|||||
M05BA03 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
IBANDRONIC ACID |
|||||
M05BA06 |
PBS/RPBS |
Plain |
0.115 |
0.188 |
0.241 |
SURVEY |
Plain |
0.000 |
0.001 |
0.006 |
|
RISEDRONIC ACID |
|||||
M05BA07 |
PBS/RPBS |
Plain |
1.608 |
2.169 |
2.419 |
PBS/RPBS |
Combination |
3.014 |
2.723 |
2.342 |
|
PBS/RPBS |
Total |
4.622 |
4.892 |
4.761 |
|
SURVEY |
Plain |
0.054 |
0.067 |
0.073 |
|
SURVEY |
Combination |
0.080 |
0.052 |
0.042 |
|
SURVEY |
Total |
0.134 |
0.119 |
0.115 |
|
TILUDRONIC ACID |
|||||
M05BA05 |
PBS/RPBS |
Plain |
0.002 |
0.002 |
0.002 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ZOLEDRONIC ACID |
|||||
M05BA08 |
PBS/RPBS |
Plain |
0.572 |
1.028 |
1.272 |
SURVEY |
Plain |
0.009 |
0.008 |
0.004 |
|
BISPHOSPHONATES, COMBINATIONS |
|||||
ALENDRONATE SODIUM with COLECALCIFEROL and CALCIUM CARBONATE |
|||||
M05BB05 |
PBS/RPBS |
Plain |
0.000 |
0.163 |
0.798 |
SURVEY |
Plain |
0.000 |
0.002 |
0.012 |
|
OTHER DRUGS AFFECTING BONE STRUCTURE |
|||||
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
|||||
DENOSUMAB |
|||||
M05BX04 |
PBS/RPBS |
Plain |
0.000 |
0.003 |
0.303 |
SURVEY |
Plain |
0.000 |
0.001 |
0.010 |
|
STRONTIUM RANELATE |
|||||
M05BX03 |
PBS/RPBS |
Plain |
0.816 |
0.999 |
1.114 |
SURVEY |
Plain |
0.034 |
0.037 |
0.042 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
MUSCULO-SKELETAL SYSTEM |
|||||
HYALURONIC ACID |
|||||
M09AX01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
NERVOUS SYSTEM |
|||||
HYDROMORPHONE |
|||||
N02AA03 |
PBS/RPBS |
Plain |
0.108 |
0.178 |
0.277 |
SURVEY |
Plain |
0.003 |
0.005 |
0.014 |
|
MORPHINE |
|||||
N02AA01 |
PBS/RPBS |
Plain |
1.470 |
1.402 |
1.304 |
SURVEY |
Plain |
0.089 |
0.077 |
0.075 |
|
OXYCODONE |
|||||
N02AA05 |
PBS/RPBS |
Plain |
2.246 |
2.480 |
2.650 |
SURVEY |
Plain |
0.214 |
0.224 |
0.233 |
|
PHENYLPIPERIDINE DERIVATIVES |
|||||
FENTANYL |
|||||
N02AB03 |
PBS/RPBS |
Plain |
0.891 |
1.078 |
1.183 |
SURVEY |
Plain |
0.007 |
0.009 |
0.008 |
|
PETHIDINE HYDROCHLORIDE |
|||||
N02AB02 |
SURVEY |
Plain |
0.003 |
0.004 |
0.005 |
DIPHENYLPROPYLAMINE DERIVATIVES |
|||||
DEXTROPROPOXYPHENE NAPSYLATE |
|||||
N02AC04 |
PBS/RPBS |
Plain |
0.019 |
0.017 |
0.013 |
SURVEY |
Plain |
0.038 |
0.043 |
0.040 |
|
SURVEY |
Combination |
0.205 |
0.194 |
0.175 |
|
SURVEY |
Total |
0.243 |
0.237 |
0.215 |
|
ORIPAVINE DERIVATIVES |
|||||
BUPRENORPHINE |
|||||
N02AE01 |
PBS/RPBS |
Plain |
0.413 |
0.502 |
0.576 |
SURVEY |
Plain |
0.011 |
0.009 |
0.011 |
|
OTHER OPIOIDS |
|||||
TRAMADOL |
|||||
N02AX02 |
PBS/RPBS |
Plain |
2.730 |
2.830 |
2.886 |
SURVEY |
Plain |
0.596 |
0.621 |
0.651 |
|
OTHER ANALGESICS AND ANTIPYRETICS |
|||||
SALICYLIC ACID DERIVATIVES |
|||||
ASPIRIN |
|||||
N02BA01 |
PBS/RPBS |
Plain |
0.146 |
0.115 |
0.093 |
PBS/RPBS |
Combination |
0.000 |
0.000 |
0.000 |
|
PBS/RPBS |
Total |
0.146 |
0.115 |
0.093 |
|
SURVEY |
Plain |
0.009 |
0.006 |
0.005 |
|
SURVEY |
Combination |
0.003 |
0.003 |
0.003 |
|
SURVEY |
Total |
0.012 |
0.009 |
0.008 |
|
ANILIDES |
|||||
PARACETAMOL |
|||||
N02BE01 |
PBS/RPBS |
Plain |
20.218 |
23.100 |
25.996 |
OTHER ANALGESICS AND ANTIPYRETICS |
|||||
PBS/RPBS |
Combination |
2.953 |
2.984 |
2.993 |
|
PBS/RPBS |
Total |
23.171 |
26.084 |
28.989 |
|
SURVEY |
Plain |
1.009 |
1.151 |
1.301 |
|
SURVEY |
Combination |
1.375 |
1.234 |
1.254 |
|
SURVEY |
Total |
2.384 |
2.385 |
2.555 |
|
ANTIMIGRAINE PREPARATIONS |
|||||
ERGOT ALKALOIDS |
|||||
DIHYDROERGOTAMINE |
|||||
N02CA01 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
METHYSERGIDE |
|||||
N02CA04 |
PBS/RPBS |
Plain |
0.024 |
0.023 |
0.022 |
SURVEY |
Plain |
0.001 |
0.001 |
0.000 |
|
SELECTIVE 5HT RECEPTOR AGONISTS |
|||||
ELETRIPTAN |
|||||
N02CC06 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.014 |
SURVEY |
Plain |
0.000 |
0.000 |
0.011 |
|
NARATRIPTAN |
|||||
N02CC02 |
PBS/RPBS |
Plain |
0.020 |
0.020 |
0.018 |
SURVEY |
Plain |
0.026 |
0.026 |
0.023 |
|
RIZATRIPTAN |
|||||
N02CC04 |
PBS/RPBS |
Plain |
0.000 |
0.008 |
0.023 |
SURVEY |
Plain |
0.000 |
0.010 |
0.028 |
|
SUMATRIPTAN |
|||||
N02CC01 |
PBS/RPBS |
Plain |
0.096 |
0.109 |
0.108 |
SURVEY |
Plain |
0.102 |
0.122 |
0.120 |
|
ZOLMITRIPTAN |
|||||
N02CC03 |
PBS/RPBS |
Plain |
0.033 |
0.032 |
0.030 |
SURVEY |
Plain |
0.039 |
0.038 |
0.037 |
|
OTHER ANTIMIGRAINE PREPARATIONS |
|||||
PIZOTIFEN MALATE |
|||||
N02CX01 |
PBS/RPBS |
Plain |
0.382 |
0.386 |
0.381 |
SURVEY |
Plain |
0.194 |
0.189 |
0.189 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
NERVOUS SYSTEM |
|||||
PHENOBARBITONE |
|||||
N03AA02 |
PBS/RPBS |
Plain |
0.091 |
0.087 |
0.082 |
SURVEY |
Plain |
0.023 |
0.024 |
0.024 |
|
PRIMIDONE |
|||||
N03AA03 |
PBS/RPBS |
Plain |
0.079 |
0.078 |
0.075 |
SURVEY |
Plain |
0.000 |
0.001 |
0.001 |
|
HYDANTOIN DERIVATIVES |
|||||
PHENYTOIN |
|||||
N03AB02 |
PBS/RPBS |
Plain |
1.053 |
1.019 |
0.965 |
SURVEY |
Plain |
0.308 |
0.268 |
0.253 |
|
SUCCINIMIDE DERIVATIVES |
|||||
ETHOSUXIMIDE |
|||||
N03AD01 |
PBS/RPBS |
Plain |
0.018 |
0.020 |
0.022 |
SURVEY |
Plain |
0.001 |
0.000 |
0.001 |
|
BENZODIAZEPINE DERIVATIVES |
|||||
CLONAZEPAM |
|||||
N03AE01 |
PBS/RPBS |
Plain |
0.133 |
0.130 |
0.127 |
SURVEY |
Plain |
0.222 |
0.228 |
0.218 |
|
CARBOXAMIDE DERIVATIVES |
|||||
CARBAMAZEPINE |
|||||
N03AF01 |
PBS/RPBS |
Plain |
1.400 |
1.391 |
1.376 |
SURVEY |
Plain |
0.290 |
0.279 |
0.274 |
|
OXCARBAZEPINE |
|||||
N03AF02 |
PBS/RPBS |
Plain |
0.071 |
0.074 |
0.076 |
SURVEY |
Plain |
0.001 |
0.002 |
0.001 |
|
FATTY ACID DERIVATIVES |
|||||
SODIUM VALPROATE |
|||||
N03AG01 |
PBS/RPBS |
Plain |
3.736 |
3.558 |
3.576 |
SURVEY |
Plain |
0.071 |
0.253 |
0.247 |
|
TIAGABINE |
|||||
N03AG06 |
PBS/RPBS |
Plain |
0.008 |
0.008 |
0.007 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
VIGABATRIN |
|||||
N03AG04 |
PBS/RPBS |
Plain |
0.042 |
0.039 |
0.037 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER ANTIEPILEPTICS |
|||||
GABAPENTIN |
|||||
N03AX12 |
PBS/RPBS |
Plain |
0.291 |
0.289 |
0.289 |
SURVEY |
Plain |
0.181 |
0.185 |
0.205 |
|
LACOSAMIDE |
|||||
N03AX18 |
PBS/RPBS |
Plain |
0.000 |
0.014 |
0.043 |
ANTIEPILEPTICS |
|||||
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
LAMOTRIGINE |
|||||
N03AX09 |
PBS/RPBS |
Plain |
0.827 |
0.843 |
0.858 |
SURVEY |
Plain |
0.121 |
0.126 |
0.133 |
|
LEVETIRACETAM |
|||||
N03AX14 |
PBS/RPBS |
Plain |
0.689 |
0.802 |
0.924 |
SURVEY |
Plain |
0.008 |
0.009 |
0.007 |
|
PREGABALIN |
|||||
N03AX16 |
PBS/RPBS |
Plain |
0.060 |
0.075 |
0.087 |
SURVEY |
Plain |
0.406 |
0.494 |
0.580 |
|
SULTHIAME |
|||||
N03AX03 |
PBS/RPBS |
Plain |
0.024 |
0.023 |
0.022 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
TOPIRAMATE |
|||||
N03AX11 |
PBS/RPBS |
Plain |
0.352 |
0.382 |
0.401 |
SURVEY |
Plain |
0.024 |
0.023 |
0.024 |
|
ZONISAMIDE |
|||||
N03AX15 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.008 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
NERVOUS SYSTEM |
|||||
BENZHEXOL HYDROCHLORIDE |
|||||
N04AA01 |
PBS/RPBS |
Plain |
0.110 |
0.101 |
0.100 |
SURVEY |
Plain |
0.013 |
0.012 |
0.014 |
|
BIPERIDEN HYDROCHLORIDE |
|||||
N04AA02 |
PBS/RPBS |
Plain |
0.057 |
0.055 |
0.053 |
SURVEY |
Plain |
0.006 |
0.006 |
0.005 |
|
ETHERS OF TROPINE OR TROPINE DERIVATIVES |
|||||
BENZTROPINE MESYLATE |
|||||
N04AC01 |
PBS/RPBS |
Plain |
0.425 |
0.416 |
0.384 |
SURVEY |
Plain |
0.036 |
0.031 |
0.034 |
|
DOPAMINERGIC AGENTS |
|||||
DOPA AND DOPA DERIVATIVES |
|||||
LEVODOPA and DECARBOXYLASE INHIBITOR |
|||||
N04BA02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.003 |
LEVODOPA with BENSERAZIDE |
|||||
N04BA02 |
PBS/RPBS |
Plain |
0.570 |
0.605 |
0.615 |
SURVEY |
Plain |
0.003 |
0.004 |
0.003 |
|
LEVODOPA with CARBIDOPA |
|||||
N04BA02 |
PBS/RPBS |
Plain |
0.846 |
0.784 |
0.773 |
SURVEY |
Plain |
0.004 |
0.003 |
0.003 |
|
LEVODOPA with CARBIDOPA and ENTACAPONE |
|||||
N04BA03 |
PBS/RPBS |
Plain |
0.000 |
0.007 |
0.024 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
LEVODOPA,DECARBOXYLASE INHIBITOR and COMT INHIBITOR |
|||||
N04BA03 |
PBS/RPBS |
Plain |
0.111 |
0.153 |
0.171 |
SURVEY |
Plain |
0.000 |
0.002 |
0.000 |
|
ADAMANTANE DERIVATIVES |
|||||
AMANTADINE HYDROCHLORIDE |
|||||
N04BB01 |
PBS/RPBS |
Plain |
0.094 |
0.094 |
0.094 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
|
DOPAMINE AGONISTS |
|||||
APOMORPHINE |
|||||
N04BC07 |
PBS/RPBS |
Plain |
0.010 |
0.011 |
0.012 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
BROMOCRIPTINE MESYLATE |
|||||
N04BC01 |
PBS/RPBS |
Plain |
0.010 |
0.008 |
0.005 |
SURVEY |
Plain |
0.002 |
0.001 |
0.001 |
|
CABERGOLINE |
|||||
N04BC06 |
PBS/RPBS |
Plain |
0.096 |
0.067 |
0.048 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
PERGOLIDE |
|||||
DOPAMINERGIC AGENTS |
|||||
N04BC02 |
PBS/RPBS |
Plain |
0.008 |
0.006 |
0.005 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
|
PRAMIPEXOLE |
|||||
N04BC05 |
PBS/RPBS |
Plain |
0.172 |
0.253 |
0.336 |
SURVEY |
Plain |
0.000 |
0.002 |
0.004 |
|
ROPINIROLE |
|||||
N04BC04 |
SURVEY |
Plain |
0.005 |
0.004 |
0.004 |
MONOAMINE OXIDASE TYPE B INHIBITORS |
|||||
SELEGILINE HYDROCHLORIDE |
|||||
N04BD01 |
PBS/RPBS |
Plain |
0.073 |
0.070 |
0.071 |
SURVEY |
Plain |
0.002 |
0.004 |
0.005 |
|
OTHER DOPAMINERGIC AGENTS |
|||||
ENTACAPONE |
|||||
N04BX02 |
PBS/RPBS |
Plain |
0.080 |
0.072 |
0.063 |
SURVEY |
Plain |
0.001 |
0.001 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
NERVOUS SYSTEM |
|||||
CHLORPROMAZINE HYDROCHLORIDE |
|||||
N05AA01 |
PBS/RPBS |
Plain |
0.146 |
0.138 |
0.134 |
SURVEY |
Plain |
0.016 |
0.015 |
0.013 |
|
PHENOTHIAZINE WITH PIPERAZINE STRUCTURE |
|||||
FLUPHENAZINE DECANOATE |
|||||
N05AB02 |
PBS/RPBS |
Plain |
0.205 |
0.192 |
0.180 |
SURVEY |
Plain |
0.006 |
0.005 |
0.003 |
|
PROCHLORPERAZINE |
|||||
N05AB04 |
PBS/RPBS |
Plain |
0.117 |
0.115 |
0.114 |
SURVEY |
Plain |
0.044 |
0.043 |
0.042 |
|
TRIFLUOPERAZINE HYDROCHLORIDE |
|||||
N05AB06 |
PBS/RPBS |
Plain |
0.058 |
0.054 |
0.050 |
SURVEY |
Plain |
0.010 |
0.007 |
0.006 |
|
PHENOTHIAZINE WITH PIPERIDINE STRUCTURE |
|||||
PERICYAZINE |
|||||
N05AC01 |
PBS/RPBS |
Plain |
0.054 |
0.052 |
0.050 |
SURVEY |
Plain |
0.007 |
0.008 |
0.009 |
|
BUTYROPHENONE DERIVATIVES |
|||||
HALOPERIDOL |
|||||
N05AD01 |
PBS/RPBS |
Plain |
0.226 |
0.217 |
0.211 |
SURVEY |
Plain |
0.016 |
0.016 |
0.016 |
|
INDOLE DERIVATIVES |
|||||
ZIPRASIDONE |
|||||
N05AE04 |
PBS/RPBS |
Plain |
0.156 |
0.181 |
0.203 |
SURVEY |
Plain |
0.048 |
0.052 |
0.050 |
|
THIOXANTHENE DERIVATIVES |
|||||
FLUPENTHIXOL |
|||||
N05AF01 |
PBS/RPBS |
Plain |
0.117 |
0.120 |
0.121 |
SURVEY |
Plain |
0.003 |
0.002 |
0.009 |
|
ZUCLOPENTHIXOL |
|||||
N05AF05 |
PBS/RPBS |
Plain |
0.210 |
0.223 |
0.121 |
SURVEY |
Plain |
0.012 |
0.010 |
0.039 |
|
DIPHENYLBUTYLPIPERIDINE DERIVATIVES |
|||||
PIMOZIDE |
|||||
N05AG02 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES |
|||||
ASENAPINE |
|||||
N05AH05 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.002 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
CLOZAPINE |
|||||
N05AH02 |
PBS/RPBS |
Plain |
0.053 |
0.056 |
0.060 |
ANTIPSYCHOTICS |
|||||
SURVEY |
Plain |
0.187 |
0.199 |
0.226 |
|
OLANZAPINE |
|||||
N05AH03 |
PBS/RPBS |
Plain |
3.044 |
3.047 |
3.085 |
SURVEY |
Plain |
0.066 |
0.043 |
0.034 |
|
QUETIAPINE |
|||||
N05AH04 |
PBS/RPBS |
Plain |
1.659 |
1.974 |
2.246 |
SURVEY |
Plain |
0.113 |
0.100 |
0.103 |
|
BENZAMIDES |
|||||
AMISULPRIDE |
|||||
N05AL05 |
PBS/RPBS |
Plain |
0.419 |
0.408 |
0.401 |
SURVEY |
Plain |
0.007 |
0.004 |
0.006 |
|
LITHIUM |
|||||
LITHIUM CARBONATE |
|||||
N05AN01 |
PBS/RPBS |
Plain |
0.914 |
0.946 |
0.975 |
SURVEY |
Plain |
0.248 |
0.238 |
0.231 |
|
OTHER ANTIPSYCHOTICS |
|||||
ARIPIPRAZOLE |
|||||
N05AX12 |
PBS/RPBS |
Plain |
0.526 |
0.565 |
0.612 |
SURVEY |
Plain |
0.012 |
0.009 |
0.012 |
|
PALIPERIDONE |
|||||
N05AX13 |
PBS/RPBS |
Plain |
0.081 |
0.099 |
0.115 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
RISPERIDONE |
|||||
N05AX08 |
PBS/RPBS |
Plain |
1.491 |
1.510 |
1.506 |
SURVEY |
Plain |
0.018 |
0.021 |
0.022 |
|
ANXIOLYTICS |
|||||
BENZODIAZEPINE DERIVATIVES |
|||||
ALPRAZOLAM |
|||||
N05BA12 |
PBS/RPBS |
Plain |
3.919 |
3.873 |
3.735 |
SURVEY |
Plain |
2.325 |
2.324 |
2.444 |
|
BROMAZEPAM |
|||||
N05BA08 |
PBS/RPBS |
Plain |
0.006 |
0.005 |
0.004 |
SURVEY |
Plain |
0.135 |
0.122 |
0.128 |
|
CLOBAZAM |
|||||
N05BA09 |
SURVEY |
Plain |
0.069 |
0.073 |
0.079 |
DIAZEPAM |
|||||
N05BA01 |
PBS/RPBS |
Plain |
4.855 |
4.732 |
4.641 |
SURVEY |
Plain |
1.528 |
1.564 |
1.611 |
|
LORAZEPAM |
|||||
N05BA06 |
SURVEY |
Plain |
0.407 |
0.413 |
0.398 |
OXAZEPAM |
|||||
N05BA04 |
PBS/RPBS |
Plain |
1.893 |
1.772 |
1.659 |
ANXIOLYTICS |
|||||
SURVEY |
Plain |
0.412 |
0.392 |
0.381 |
|
AZASPIRODECANEDIONE DERIVATIVES |
|||||
BUSPIRONE HYDROCHLORIDE |
|||||
N05BE01 |
PBS/RPBS |
Plain |
0.002 |
0.002 |
0.002 |
SURVEY |
Plain |
0.008 |
0.007 |
0.011 |
|
HYPNOTICS AND SEDATIVES |
|||||
ALDEHYDES AND DERIVATIVES |
|||||
CHLORAL HYDRATE |
|||||
N05CC01 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
BENZODIAZEPINE DERIVATIVES |
|||||
FLUNITRAZEPAM |
|||||
N05CD03 |
PBS/RPBS |
Plain |
0.037 |
0.032 |
0.027 |
SURVEY |
Plain |
0.291 |
0.266 |
0.243 |
|
MIDAZOLAM |
|||||
N05CD08 |
SURVEY |
Plain |
0.007 |
0.008 |
0.011 |
NITRAZEPAM |
|||||
N05CD02 |
PBS/RPBS |
Plain |
1.561 |
1.435 |
1.304 |
SURVEY |
Plain |
0.288 |
0.286 |
0.271 |
|
TEMAZEPAM |
|||||
N05CD07 |
PBS/RPBS |
Plain |
3.290 |
3.108 |
2.963 |
SURVEY |
Plain |
1.050 |
0.984 |
1.001 |
|
TRIAZOLAM |
|||||
N05CD05 |
SURVEY |
Plain |
0.017 |
0.021 |
0.028 |
BENZODIAZEPINE RELATED DRUGS |
|||||
ZOLPIDEM |
|||||
N05CF02 |
SURVEY |
Plain |
0.810 |
0.744 |
0.783 |
ZOPICLONE |
|||||
N05CF01 |
PBS/RPBS |
Plain |
0.100 |
0.098 |
0.095 |
SURVEY |
Plain |
0.382 |
0.411 |
0.513 |
|
BENZODIAZEPINE RELATED DRUGS |
|||||
MELATONIN |
|||||
N05CH01 |
SURVEY |
Plain |
0.000 |
0.106 |
0.177 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
NERVOUS SYSTEM |
|||||
AMITRIPTYLINE HYDROCHLORIDE |
|||||
N06AA09 |
PBS/RPBS |
Plain |
2.871 |
2.981 |
3.088 |
SURVEY |
Plain |
0.889 |
0.873 |
0.908 |
|
CLOMIPRAMINE HYDROCHLORIDE |
|||||
N06AA04 |
PBS/RPBS |
Plain |
0.193 |
0.192 |
0.193 |
SURVEY |
Plain |
0.055 |
0.054 |
0.057 |
|
DOTHIEPIN HYDROCHLORIDE |
|||||
N06AA16 |
PBS/RPBS |
Plain |
0.798 |
0.762 |
0.693 |
SURVEY |
Plain |
0.307 |
0.281 |
0.291 |
|
DOXEPIN HYDROCHLORIDE |
|||||
N06AA12 |
PBS/RPBS |
Plain |
0.682 |
0.640 |
0.596 |
SURVEY |
Plain |
0.128 |
0.109 |
0.101 |
|
IMIPRAMINE HYDROCHLORIDE |
|||||
N06AA02 |
PBS/RPBS |
Plain |
0.224 |
0.208 |
0.197 |
SURVEY |
Plain |
0.056 |
0.049 |
0.045 |
|
NORTRIPTYLINE HYDROCHLORIDE |
|||||
N06AA10 |
PBS/RPBS |
Plain |
0.184 |
0.195 |
0.210 |
SURVEY |
Plain |
0.081 |
0.082 |
0.079 |
|
TRIMIPRAMINE MALEATE |
|||||
N06AA06 |
SURVEY |
Plain |
0.016 |
0.015 |
0.016 |
SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
|||||
CITALOPRAM |
|||||
N06AB04 |
PBS/RPBS |
Plain |
5.869 |
5.780 |
5.381 |
SURVEY |
Plain |
2.007 |
1.767 |
2.080 |
|
ESCITALOPRAM |
|||||
N06AB10 |
PBS/RPBS |
Plain |
6.136 |
7.114 |
7.958 |
SURVEY |
Plain |
4.602 |
4.886 |
5.072 |
|
FLUOXETINE HYDROCHLORIDE |
|||||
N06AB03 |
PBS/RPBS |
Plain |
4.351 |
4.428 |
3.814 |
SURVEY |
Plain |
2.105 |
2.069 |
2.448 |
|
FLUVOXAMINE |
|||||
N06AB08 |
PBS/RPBS |
Plain |
1.401 |
1.353 |
1.297 |
SURVEY |
Plain |
0.595 |
0.534 |
0.502 |
|
PAROXETINE |
|||||
N06AB05 |
PBS/RPBS |
Plain |
3.686 |
3.568 |
3.487 |
SURVEY |
Plain |
1.639 |
1.497 |
1.453 |
|
SERTRALINE |
|||||
N06AB06 |
PBS/RPBS |
Plain |
12.444 |
12.516 |
12.532 |
SURVEY |
Plain |
6.675 |
6.276 |
6.392 |
|
MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE |
|||||
PHENELZINE SULPHATE |
|||||
ANTIDEPRESSANTS |
|||||
N06AF03 |
PBS/RPBS |
Plain |
0.029 |
0.030 |
0.030 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
TRANYLCYPROMINE SULPHATE |
|||||
N06AF04 |
PBS/RPBS |
Plain |
0.244 |
0.247 |
0.234 |
SURVEY |
Plain |
0.003 |
0.004 |
0.034 |
|
MONOAMINE OXIDASE TYPE A INHIBITORS |
|||||
MOCLOBEMIDE |
|||||
N06AG02 |
PBS/RPBS |
Plain |
0.825 |
0.759 |
0.698 |
SURVEY |
Plain |
0.295 |
0.242 |
0.279 |
|
OTHER ANTIDEPRESSANTS |
|||||
AGOMELATINE |
|||||
N06AX22 |
SURVEY |
Plain |
0.000 |
0.010 |
0.133 |
BUPROPION |
|||||
N06AX12 |
PBS/RPBS |
Plain |
0.064 |
0.062 |
0.052 |
SURVEY |
Plain |
0.015 |
0.015 |
0.019 |
|
DESVENLAFAXINE |
|||||
N06AX23 |
PBS/RPBS |
Plain |
1.467 |
3.976 |
6.059 |
SURVEY |
Plain |
0.013 |
0.027 |
0.045 |
|
DULOXETINE |
|||||
N06AX21 |
PBS/RPBS |
Plain |
1.511 |
2.550 |
3.423 |
SURVEY |
Plain |
0.026 |
0.037 |
0.049 |
|
MIANSERIN HYDROCHLORIDE |
|||||
N06AX03 |
PBS/RPBS |
Plain |
0.135 |
0.129 |
0.123 |
SURVEY |
Plain |
0.021 |
0.018 |
0.017 |
|
MIRTAZAPINE |
|||||
N06AX11 |
PBS/RPBS |
Plain |
4.735 |
5.113 |
5.460 |
SURVEY |
Plain |
0.820 |
0.763 |
0.740 |
|
REBOXETINE |
|||||
N06AX18 |
PBS/RPBS |
Plain |
0.305 |
0.269 |
0.234 |
SURVEY |
Plain |
0.003 |
0.001 |
0.001 |
|
VENLAFAXINE |
|||||
N06AX16 |
PBS/RPBS |
Plain |
13.278 |
12.586 |
12.150 |
SURVEY |
Plain |
0.198 |
0.156 |
0.154 |
|
PSYCHOSTIMULANTS AND NOOTROPICS |
|||||
CENTRALLY ACTING SYMPATHOMIMETICS |
|||||
ATOMOXETINE |
|||||
N06BA09 |
PBS/RPBS |
Plain |
0.086 |
0.097 |
0.102 |
SURVEY |
Plain |
0.006 |
0.007 |
0.005 |
|
DEXAMPHETAMINE SULPHATE |
|||||
N06BA02 |
PBS/RPBS |
Plain |
1.064 |
1.087 |
0.993 |
SURVEY |
Plain |
0.730 |
0.735 |
0.677 |
|
METHYLPHENIDATE |
|||||
PSYCHOSTIMULANTS AND NOOTROPICS |
|||||
N06BA04 |
PBS/RPBS |
Plain |
1.574 |
1.733 |
1.882 |
SURVEY |
Plain |
0.293 |
0.271 |
0.295 |
|
MODAFINIL |
|||||
N06BA07 |
PBS/RPBS |
Plain |
0.013 |
0.021 |
0.028 |
SURVEY |
Plain |
0.014 |
0.015 |
0.024 |
|
ANTI-DEMENTIA DRUGS |
|||||
ANTICHOLINESTERASES |
|||||
DONEPEZIL |
|||||
N06DA02 |
PBS/RPBS |
Plain |
1.005 |
1.013 |
1.032 |
SURVEY |
Plain |
0.014 |
0.017 |
0.019 |
|
GALANTAMINE |
|||||
N06DA04 |
PBS/RPBS |
Plain |
0.395 |
0.379 |
0.358 |
SURVEY |
Plain |
0.006 |
0.007 |
0.006 |
|
RIVASTIGMINE |
|||||
N06DA03 |
PBS/RPBS |
Plain |
0.080 |
0.106 |
0.129 |
SURVEY |
Plain |
0.001 |
0.002 |
0.003 |
|
OTHER ANTI-DEMENTIA DRUGS |
|||||
MEMANTINE HYDROCHLORIDE |
|||||
N06DX01 |
PBS/RPBS |
Plain |
0.041 |
0.058 |
0.069 |
SURVEY |
Plain |
0.035 |
0.033 |
0.035 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
NERVOUS SYSTEM |
|||||
PYRIDOSTIGMINE BROMIDE |
|||||
N07AA02 |
PBS/RPBS |
Plain |
0.111 |
0.116 |
0.118 |
SURVEY |
Plain |
0.002 |
0.002 |
0.002 |
|
CHOLINE ESTERS |
|||||
BETHANECHOL CHLORIDE |
|||||
N07AB02 |
PBS/RPBS |
Plain |
0.019 |
0.018 |
0.016 |
SURVEY |
Plain |
0.005 |
0.005 |
0.005 |
|
DRUGS USED IN ADDICTIVE DISORDERS |
|||||
DRUGS USED IN NICOTINE DEPENDENCE |
|||||
NICOTINE |
|||||
N07BA01 |
PBS/RPBS |
Plain |
0.008 |
0.010 |
1.147 |
SURVEY |
Plain |
0.001 |
0.004 |
0.009 |
|
VARENICLINE |
|||||
N07BA03 |
PBS/RPBS |
Plain |
2.069 |
2.152 |
1.778 |
SURVEY |
Plain |
0.087 |
0.101 |
0.068 |
|
DRUGS USED IN ALCOHOL DEPENDENCE |
|||||
ACAMPROSATE |
|||||
N07BB03 |
PBS/RPBS |
Plain |
0.114 |
0.114 |
0.118 |
SURVEY |
Plain |
0.002 |
0.001 |
0.002 |
|
NALTREXONE |
|||||
N07BB04 |
PBS/RPBS |
Plain |
0.087 |
0.091 |
0.092 |
SURVEY |
Plain |
0.003 |
0.002 |
0.004 |
|
DRUGS USED IN OPIOID DEPENDENCE |
|||||
BUPRENORPHINE |
|||||
N07BC01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
BUPRENORPHINE with NALOXONE |
|||||
N07BC51 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
METHADONE HYDROCHLORIDE |
|||||
N07BC02 |
PBS/RPBS |
Plain |
0.372 |
0.367 |
0.377 |
SURVEY |
Plain |
0.166 |
0.256 |
0.142 |
|
ANTIVERTIGO PREPARATIONS |
|||||
ANTIVERTIGO PREPARATIONS |
|||||
BETAHISTINE |
|||||
N07CA01 |
SURVEY |
Plain |
0.370 |
0.395 |
0.367 |
OTHER NERVOUS SYSTEM DRUGS |
|||||
OTHER NERVOUS SYSTEM DRUGS |
|||||
FAMPRIDINE |
|||||
N07XX07 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
RILUZOLE |
|||||
N07XX02 |
PBS/RPBS |
Plain |
0.027 |
0.027 |
0.027 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
OTHER NERVOUS SYSTEM DRUGS |
|||||
TETRABENAZINE |
|||||
N07XX06 |
PBS/RPBS |
Plain |
0.022 |
0.022 |
0.023 |
SURVEY |
Plain |
0.000 |
0.001 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
|||||
METRONIDAZOLE |
|||||
P01AB01 |
PBS/RPBS |
Plain |
0.135 |
0.140 |
0.143 |
SURVEY |
Plain |
0.173 |
0.172 |
0.172 |
|
TINIDAZOLE |
|||||
P01AB02 |
PBS/RPBS |
Plain |
0.006 |
0.006 |
0.006 |
SURVEY |
Plain |
0.014 |
0.014 |
0.014 |
|
OTHER AGENTS AGAINST AMOEBIASIS |
|||||
ATOVAQUONE |
|||||
P01AX06 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ANTIMALARIALS |
|||||
QUINOLINE DERIVATIVES |
|||||
CHLOROQUINE |
|||||
P01BA01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
HYDROXYCHLOROQUINE SULPHATE |
|||||
P01BA02 |
PBS/RPBS |
Plain |
0.646 |
0.700 |
0.753 |
SURVEY |
Plain |
0.006 |
0.007 |
0.007 |
|
PRIMAQUINE PHOSPHATE |
|||||
P01BA03 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
BIGUANIDES |
|||||
PROGUANIL |
|||||
P01BB01 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
METHANOLQUINOLINES |
|||||
MEFLOQUINE |
|||||
P01BC02 |
SURVEY |
Plain |
0.003 |
0.004 |
0.004 |
QUININE |
|||||
P01BC01 |
PBS/RPBS |
Plain |
0.007 |
0.005 |
0.004 |
SURVEY |
Plain |
0.176 |
0.120 |
0.091 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
|||||
PRAZIQUANTEL |
|||||
P02BA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
ANTINEMATODAL AGENTS |
|||||
BENZIMIDAZOLE DERIVATIVES |
|||||
ALBENDAZOLE |
|||||
P02CA03 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.001 |
0.001 |
|
MEBENDAZOLE |
|||||
P02CA01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
TETRAHYDROPYRIMIDINE DERIVATIVES |
|||||
PYRANTEL EMBONATE |
|||||
P02CC01 |
PBS/RPBS |
Plain |
0.001 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
AVERMECTINES |
|||||
IVERMECTIN |
|||||
P02CF01 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
RESPIRATORY SYSTEM |
|||||
OXYMETAZOLINE |
|||||
R01AA05 |
PBS/RPBS |
Plain |
0.004 |
0.002 |
0.002 |
SURVEY |
Plain |
0.004 |
0.003 |
0.002 |
|
XYLOMETAZOLINE |
|||||
R01AA07 |
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
ANTIALLERGIC AGENTS,EXCL.CORTICOSTEROIDS |
|||||
LEVOCABASTINE |
|||||
R01AC02 |
PBS/RPBS |
Plain |
0.002 |
0.001 |
0.001 |
SURVEY |
Plain |
0.001 |
0.000 |
0.001 |
|
SODIUM CROMOGLYCATE |
|||||
R01AC01 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
CORTICOSTEROIDS |
|||||
BECLOMETHASONE DIPROPIONATE |
|||||
R01AD01 |
SURVEY |
Plain |
0.008 |
0.010 |
0.009 |
BUDESONIDE |
|||||
R01AD05 |
PBS/RPBS |
Plain |
0.090 |
0.083 |
0.078 |
SURVEY |
Plain |
1.117 |
0.945 |
0.901 |
|
FLUTICASONE |
|||||
R01AD08 |
SURVEY |
Plain |
0.007 |
0.019 |
0.038 |
FLUTICASONE FUROATE |
|||||
R01AD12 |
SURVEY |
Plain |
0.196 |
0.387 |
0.123 |
MOMETASONE FUROATE |
|||||
R01AD09 |
SURVEY |
Plain |
2.371 |
2.377 |
2.522 |
OTHER NASAL PREPARATIONS |
|||||
IPRATROPIUM BROMIDE |
|||||
R01AX03 |
PBS/RPBS |
Plain |
0.043 |
0.039 |
0.036 |
SURVEY |
Plain |
0.014 |
0.015 |
0.015 |
|
NASAL DECONGESTANTS FOR SYSTEMIC USE |
|||||
SYMPATHOMIMETICS |
|||||
PSEUDOEPHEDRINE |
|||||
R01BA02 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.007 |
0.009 |
0.006 |
|
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
0.007 |
0.009 |
0.006 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
RESPIRATORY SYSTEM |
|||||
EFORMOTEROL |
|||||
R03AC13 |
PBS/RPBS |
Plain |
0.299 |
0.267 |
0.238 |
PBS/RPBS |
Combination |
4.709 |
5.238 |
5.644 |
|
PBS/RPBS |
Total |
5.008 |
5.505 |
5.882 |
|
SURVEY |
Plain |
0.007 |
0.006 |
0.004 |
|
SURVEY |
Combination |
0.020 |
0.020 |
0.019 |
|
SURVEY |
Total |
0.027 |
0.026 |
0.023 |
|
INDACATEROL |
|||||
R03AC18 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.009 |
SURVEY |
Plain |
0.000 |
0.000 |
0.001 |
|
SALBUTAMOL |
|||||
R03AC02 |
PBS/RPBS |
Plain |
15.775 |
16.093 |
16.246 |
SURVEY |
Plain |
4.864 |
4.737 |
4.527 |
|
SALMETEROL |
|||||
R03AC12 |
PBS/RPBS |
Plain |
0.150 |
0.139 |
0.132 |
PBS/RPBS |
Combination |
11.125 |
11.314 |
11.554 |
|
PBS/RPBS |
Total |
11.275 |
11.453 |
11.686 |
|
SURVEY |
Plain |
0.001 |
0.001 |
0.001 |
|
SURVEY |
Combination |
0.027 |
0.028 |
0.028 |
|
SURVEY |
Total |
0.028 |
0.029 |
0.029 |
|
TERBUTALINE SULPHATE |
|||||
R03AC03 |
PBS/RPBS |
Plain |
1.276 |
1.166 |
1.065 |
SURVEY |
Plain |
0.509 |
0.424 |
0.377 |
|
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTS |
|||||
GLUCOCORTICOIDS |
|||||
BECLOMETHASONE DIPROPIONATE |
|||||
R03BA01 |
PBS/RPBS |
Plain |
0.261 |
0.235 |
0.159 |
SURVEY |
Plain |
0.010 |
0.009 |
0.057 |
|
BUDESONIDE |
|||||
R03BA02 |
PBS/RPBS |
Plain |
1.624 |
1.449 |
1.300 |
PBS/RPBS |
Combination |
4.634 |
5.159 |
5.563 |
|
PBS/RPBS |
Total |
6.258 |
6.608 |
6.863 |
|
SURVEY |
Plain |
0.202 |
0.178 |
0.174 |
|
SURVEY |
Combination |
0.019 |
0.020 |
0.019 |
|
SURVEY |
Total |
0.221 |
0.198 |
0.193 |
|
CICLESONIDE |
|||||
R03BA08 |
PBS/RPBS |
Plain |
1.126 |
1.188 |
1.297 |
SURVEY |
Plain |
0.035 |
0.040 |
0.043 |
|
FLUTICASONE |
|||||
R03BA05 |
PBS/RPBS |
Plain |
1.131 |
1.109 |
1.079 |
PBS/RPBS |
Combination |
14.569 |
14.920 |
15.346 |
|
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,INHALANTS |
|||||
PBS/RPBS |
Total |
15.700 |
16.029 |
16.425 |
|
SURVEY |
Plain |
0.392 |
0.383 |
0.366 |
|
SURVEY |
Combination |
0.030 |
0.032 |
0.030 |
|
SURVEY |
Total |
0.422 |
0.415 |
0.396 |
|
ANTICHOLINERGICS |
|||||
IPRATROPIUM BROMIDE |
|||||
R03BB01 |
PBS/RPBS |
Plain |
3.693 |
3.388 |
3.030 |
SURVEY |
Plain |
0.033 |
0.030 |
0.118 |
|
TIOTROPIUM BROMIDE |
|||||
R03BB04 |
PBS/RPBS |
Plain |
6.023 |
6.382 |
6.672 |
SURVEY |
Plain |
0.006 |
0.007 |
0.006 |
|
ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDS |
|||||
NEDOCROMIL |
|||||
R03BC03 |
PBS/RPBS |
Plain |
0.215 |
0.209 |
0.209 |
SURVEY |
Plain |
0.003 |
0.002 |
0.002 |
|
SODIUM CROMOGLYCATE |
|||||
R03BC01 |
PBS/RPBS |
Plain |
0.058 |
0.052 |
0.047 |
SURVEY |
Plain |
0.003 |
0.004 |
0.004 |
|
ADRENERGICS FOR SYSTEMIC USE |
|||||
SELECTIVE BETA-2-ADRENOCEPTOR AGONISTS |
|||||
SALBUTAMOL |
|||||
R03CC02 |
PBS/RPBS |
Plain |
0.037 |
0.034 |
0.032 |
SURVEY |
Plain |
0.013 |
0.012 |
0.012 |
|
TERBUTALINE SULPHATE |
|||||
R03CC03 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Plain |
0.143 |
0.134 |
0.103 |
|
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
|||||
XANTHINES |
|||||
THEOPHYLLINE |
|||||
R03DA04 |
PBS/RPBS |
Plain |
0.386 |
0.360 |
0.341 |
SURVEY |
Plain |
0.083 |
0.065 |
0.077 |
|
LEUKOTRIENERECEPTOR ANTAGONISTS |
|||||
MONTELUKAST |
|||||
R03DC03 |
PBS/RPBS |
Plain |
0.291 |
0.328 |
0.350 |
SURVEY |
Plain |
0.160 |
0.162 |
0.165 |
|
ZAFIRLUKAST |
|||||
R03DC01 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
|||||
OMALIZUMAB |
|||||
R03DX05 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
RESPIRATORY SYSTEM |
|||||
ACETYLCYSTEINE |
|||||
R05CB01 |
PBS/RPBS |
Plain |
0.016 |
0.002 |
0.000 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
BROMHEXINE HYDROCHLORIDE |
|||||
R05CB02 |
SURVEY |
Plain |
0.013 |
0.014 |
0.017 |
DORNASE ALFA (DESOXYRIBONUCLEASE) |
|||||
R05CB13 |
PBS/RPBS |
Plain |
0.000 |
0.000 |
0.000 |
COUGH SUPPRESSANTS, EXCL.COMBINATIONS WITH EXPECTORANTS |
|||||
OPIUM ALKALOIDS AND DERIVATIVES |
|||||
CODEINE |
|||||
R05DA04 |
PBS/RPBS |
Plain |
0.127 |
0.127 |
0.126 |
PBS/RPBS |
Combination |
5.286 |
5.346 |
5.365 |
|
PBS/RPBS |
Total |
5.413 |
5.473 |
5.491 |
|
SURVEY |
Plain |
0.035 |
0.035 |
0.039 |
|
SURVEY |
Combination |
2.181 |
1.892 |
1.920 |
|
SURVEY |
Total |
2.216 |
1.927 |
1.959 |
|
CODEINE with PSEUDOEPHEDRINE |
|||||
R05DA20 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PHOLCODINE |
|||||
R05DA08 |
PBS/RPBS |
Plain |
0.001 |
0.001 |
0.001 |
SURVEY |
Plain |
0.001 |
0.001 |
0.002 |
|
PHOLCODINE with PSEUDOEPHEDRINE |
|||||
R05DA20 |
SURVEY |
Plain |
0.001 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
RESPIRATORY SYSTEM |
|||||
DIMENHYDRINATE |
|||||
R06AA02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
DIPHENHYDRAMINE |
|||||
R06AA02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
SUBSTITUTED ALKYLAMINES |
|||||
BROMPHENIRAMINE COMBINATIONS |
|||||
R06AB51 |
SURVEY |
Plain |
0.003 |
0.000 |
0.000 |
CHLORPHENIRAMINE |
|||||
R06AB04 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
SURVEY |
Combination |
0.000 |
0.000 |
0.000 |
|
SURVEY |
Total |
0.000 |
0.000 |
0.000 |
|
DEXCHLORPHENIRAMINE |
|||||
R06AB02 |
SURVEY |
Plain |
0.044 |
0.022 |
0.018 |
PHENIRAMINE |
|||||
R06AB05 |
SURVEY |
Plain |
0.005 |
0.004 |
0.005 |
PHENOTHIAZINE DERIVATIVES |
|||||
PROMETHAZINE |
|||||
R06AD02 |
PBS/RPBS |
Plain |
0.104 |
0.092 |
0.091 |
SURVEY |
Plain |
0.235 |
0.220 |
0.220 |
|
TRIMEPRAZINE |
|||||
R06AD01 |
SURVEY |
Plain |
0.004 |
0.003 |
0.006 |
PIPERAZINE DERIVATIVES |
|||||
CETIRIZINE |
|||||
R06AE07 |
PBS/RPBS |
Plain |
0.051 |
0.048 |
0.046 |
SURVEY |
Plain |
0.020 |
0.020 |
0.028 |
|
OTHER ANTIHISTAMINES FOR SYSTEMIC USE |
|||||
CYPROHEPTADINE HYDROCHLORIDE |
|||||
R06AX02 |
PBS/RPBS |
Plain |
0.277 |
0.269 |
0.263 |
SURVEY |
Plain |
0.046 |
0.041 |
0.038 |
|
DESLORATADINE |
|||||
R06AX27 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
FEXOFENADINE |
|||||
R06AX26 |
PBS/RPBS |
Plain |
0.534 |
0.504 |
0.462 |
SURVEY |
Plain |
0.077 |
0.041 |
0.052 |
|
LORATADINE |
|||||
R06AX13 |
PBS/RPBS |
Plain |
0.128 |
0.121 |
0.114 |
SURVEY |
Plain |
0.024 |
0.030 |
0.028 |
|
LORATADINE with PSEUDOEPHEDRINE |
|||||
R06AX13 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
SENSORY ORGANS |
|||||
APRACLONIDINE |
|||||
S01EA03 |
PBS/RPBS |
Plain |
0.030 |
0.032 |
0.027 |
SURVEY |
Plain |
0.001 |
0.001 |
0.000 |
|
BRIMONIDINE |
|||||
S01EA05 |
PBS/RPBS |
Plain |
0.589 |
0.584 |
0.632 |
SURVEY |
Plain |
0.067 |
0.065 |
0.069 |
|
DIPIVEFRINE |
|||||
S01EA02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PARASYMPATHOMIMETICS |
|||||
CARBACHOL |
|||||
S01EB02 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
PILOCARPINE |
|||||
S01EB01 |
PBS/RPBS |
Plain |
0.280 |
0.242 |
0.221 |
SURVEY |
Plain |
0.034 |
0.031 |
0.029 |
|
CARBONIC ANHYDRASE INHIBITORS |
|||||
ACETAZOLAMIDE |
|||||
S01EC01 |
PBS/RPBS |
Plain |
0.082 |
0.083 |
0.083 |
SURVEY |
Plain |
0.040 |
0.038 |
0.041 |
|
BRINZOLAMIDE |
|||||
S01EC04 |
PBS/RPBS |
Plain |
0.601 |
0.663 |
0.709 |
SURVEY |
Plain |
0.078 |
0.085 |
0.083 |
|
DORZOLAMIDE |
|||||
S01EC03 |
PBS/RPBS |
Plain |
0.109 |
0.107 |
0.107 |
SURVEY |
Plain |
0.017 |
0.015 |
0.015 |
|
BETA BLOCKING AGENTS |
|||||
BETAXOLOL HYDROCHLORIDE |
|||||
S01ED02 |
PBS/RPBS |
Plain |
0.310 |
0.264 |
0.227 |
SURVEY |
Plain |
0.037 |
0.034 |
0.030 |
|
TIMOLOL MALEATE |
|||||
S01ED01 |
PBS/RPBS |
Plain |
1.106 |
0.975 |
0.861 |
SURVEY |
Plain |
0.171 |
0.149 |
0.141 |
|
PROSTAGLANDIN ANALOGUES |
|||||
BIMATOPROST |
|||||
S01EE03 |
PBS/RPBS |
Plain |
1.108 |
1.043 |
1.002 |
SURVEY |
Plain |
0.004 |
0.003 |
0.004 |
|
LATANOPROST |
|||||
S01EE01 |
PBS/RPBS |
Plain |
4.702 |
4.726 |
4.726 |
SURVEY |
Plain |
0.015 |
0.015 |
0.014 |
|
TRAVOPROST |
|||||
S01EE04 |
PBS/RPBS |
Plain |
0.417 |
0.448 |
0.465 |
SURVEY |
Plain |
0.002 |
0.003 |
0.004 |
ATC | PLAIN/ SOURCE |
COMBINATION | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
VARIOUS |
|||||
LANTHANUM CARBONATE |
|||||
V03AE03 |
PBS/RPBS |
Plain |
0.003 |
0.013 |
0.021 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
SEVELAMER |
|||||
V03AE02 |
PBS/RPBS |
Plain |
0.054 |
0.056 |
0.058 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |
|
DETOXIFYING AGENTS FOR CYTOSTATIC TREATMENT |
|||||
CALCIUM FOLINATE |
|||||
V03AF03 |
PBS/RPBS |
Plain |
0.032 |
0.030 |
0.030 |
SURVEY |
Plain |
0.000 |
0.000 |
0.000 |